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A B S T R A C T
Background
Good unaided distance visual acuity (VA) is now a realistic expectation following cataract surgery and intraocular lens (IOL) implanta-
tion. Near vision, however, still requires additional refractive power, usually in the form of reading glasses. Multiple optic (multifocal)
IOLs are available which claim to allow good vision at a range of distances. It is unclear whether this benefit outweighs the optical
compromises inherent in multifocal IOLs.
Objectives
To assess the visual effects of multifocal IOLs in comparison with the current standard treatment of monofocal lens implantation.
Search methods
We searched CENTRAL (which contains the Cochrane Eyes and Vision Trials Register) (2016, Issue 5), Ovid MEDLINE, Ovid
MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to June
2016), Embase (January 1980 to June 2016), the ISRCTN registry (www.isrctn.com/editAdvancedSearch), ClinicalTrials.gov (
www.clinicaltrials.gov), and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (
www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched
the electronic databases on 13 June 2016.
Selection criteria
All randomised controlled trials comparing a multifocal IOL of any type with a monofocal IOL as control were included. Both unilateral
and bilateral implantation trials were included. We also considered trials comparing multifocal IOLs with “monovision” whereby one
eye is corrected for distance vision and one eye corrected for near vision.
Data collection and analysis
We used standard methodological procedures expected by Cochrane. We assessed the ’certainty’ of the evidence using GRADE.
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Main results
We found 20 eligible trials that enrolled 2230 people with data available on 2061 people (3194 eyes). These trials were conducted in
Europe (13), China (three), USA (one), Middle East (one), India (one) and one multicentre study in Europe and the USA. Most of
these trials compared multifocal with monofocal lenses; two trials compared multifocal lenses with monovision. There was considerable
variety in the make and model of lenses implanted. Overall we considered the trials at risk of performance and detection bias because
it was difficult to mask participants and outcome assessors. It was also difficult to assess the role of reporting bias.
There was moderate-certainty evidence that the distance acuity achieved with multifocal lenses was not different to that achieved with
monofocal lenses (unaided VA worse than 6/6: pooled RR 0.96, 95% confidence interval (CI) 0.89 to 1.03; eyes = 682; studies = 8).
People receiving multifocal lenses may achieve better near vision (RR for unaided near VA worse than J3/J4 was 0.20, 95% CI 0.07
to 0.58; eyes = 782; studies = 8). We judged this to be low-certainty evidence because of risk of bias in the included studies and high
heterogeneity (I2 = 93%) although all included studies favoured multifocal lenses with respect to this outcome.
People receiving multifocal lenses may be less spectacle dependent (RR 0.63, 95% CI 0.55 to 0.73; eyes = 1000; studies = 10). We
judged this to be low-certainty evidence because of risk of bias and evidence of publication bias (skewed funnel plot). There was also
high heterogeneity (I2 = 67%) but all studies favoured multifocal lenses. We did not additionally downgrade for this.
Adverse subjective visual phenomena were more prevalent and more troublesome in participants with a multifocal IOL compared with
monofocals (RR for glare 1.41, 95% CI 1.03 to 1.93; eyes = 544; studies = 7, low-certainty evidence and RR for haloes 3.58, 95% CI
1.99 to 6.46; eyes = 662; studies = 7; moderate-certainty evidence).
Two studies compared multifocal lenses with monovision. There was no evidence for any important differences in distance VA between
the groups (mean difference (MD) 0.02 logMAR, 95% CI -0.02 to 0.06; eyes = 186; studies = 1), unaided intermediate VA (MD 0.07
logMAR, 95% CI 0.04 to 0.10; eyes = 181; studies = 1) and unaided near VA (MD -0.04, 95% CI -0.08 to 0.00; eyes = 186; studies =
1) compared with people receiving monovision. People receiving multifocal lenses were less likely to be spectacle dependent (RR 0.40,
95% CI 0.30 to 0.53; eyes = 262; studies = 2) but more likely to report problems with glare (RR 1.41, 95% CI 1.14 to 1.73; eyes =
187; studies = 1) compared with people receiving monovision. In one study, the investigators noted that more people in the multifocal
group underwent IOL exchange in the first year after surgery (6 participants with multifocal vs 0 participants with monovision).
Authors’ conclusions
Multifocal IOLs are effective at improving near vision relative to monofocal IOLs although there is uncertainty as to the size of the
effect. Whether that improvement outweighs the adverse effects of multifocal IOLs, such as glare and haloes, will vary between people.
Motivation to achieve spectacle independence is likely to be the deciding factor.
P L A I N L A N G U A G E S U M M A R Y
Multifocal versus monofocal intraocular lenses for people having cataract surgery
What is the aim of this review?
The aim of this Cochrane Review was to assess the effects of multifocal compared with monofocal intraocular lenses after cataract
extraction. Cochrane researchers collected and analysed all relevant studies to answer this question and found 20 studies.
Key messages
The review shows that people who have a multifocal intraocular lens after their cataract is removed may be less likely to need additional
spectacles. However, they may experience more visual problems, such as glare or haloes (rings around lights), compared with people
who have monofocal lenses.
What was studied in the review?
As people get older, sometimes the lens of the eye becomes cloudy leading to loss of vision. The cloudy lens is known as a ’cataract’. The
cataract can be removed and a replacement lens put in its place. Usually the replacement lens has one ’point of focus’. This means that
a person’s vision after cataract surgery is either good for distance vision (driving, watching television) or good for near vision (reading,
sewing) but not good for both. This standard lens is known as a ’monofocal’ lens. People who get a monofocal lens will need to use
spectacles for either distance or, more usually, for near vision.
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To address this problem, new lenses have been developed that provide two or more points of focus. These are known as ’multifocal’
lenses. These are designed to reduce the need for spectacles. People with multifocal lenses may have more vision problems such as glare
and seeing haloes. Another option is to put a different monofocal lens in each eye: one with a focus for near vision and one with a focus
for distance vision. This is known as ’monovision’.
What are the main results of the review?
TheCochrane researchers found 20 relevant studies that were mainly conducted in Europe andNorthAmerica (15 studies); three studies
were conducted in China and one study each in the Middle East and India. Eighteen studies compared multifocal with monofocal
lenses and two studies compared multifocal lenses with monovision.
The Cochrane researchers assessed how certain the evidence is for each review finding. They looked for factors that can make the
evidence less certain, such as problems with the way the studies were done, very small studies, and inconsistent findings across studies.
They also looked for factors that can make the evidence more certain, including very large effects. They graded each finding as very
low, low, moderate or high certainty
The review shows that:
• People with multifocal lenses probably have distance vision that is not very different to the distance vision of people who have standard
monofocal lenses after cataract extraction (moderate-certainty evidence). However, people with multifocal lenses may have better near
vision and may be less likely to need spectacles compared with people with monofocal lenses (low-certainty evidence).
• People who have multifocal lenses may be more likely to experience haloes and glare compared with people who have monofocal
lenses (low-certainty evidence).
• People receiving multifocal lenses had similar distance vision and near vision compared with people receiving monovision but reported
less spectacle dependence. People with multifocal lenses reported more problems with glare and haloes compared with people with
monovision.
How up-to-date is this review?
The Cochrane researchers searched for studies that had been published up to 13 June 2016.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
M ultifocal compared to monofocal intraocular lenses after cataract extraction
Patient or population: people with cataract
Settings: eye hospital
Intervention: mult if ocal intraocular lens
Comparison: monofocal intraocular lens
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Assumed risk Corresponding risk
M onofocal intraocular
lens
M ultifocal intraocular
lens
Unaided distance vi-
sual acuity worse than
6/ 6
Follow-up: 6 weeks to
18 months
800 per 1000 768 per 1000
(712 to 824)
RR 0.96
(0.89 to 1.03)
682
(8 studies)
⊕⊕⊕©
M oderate1
-
Corrected distance vi-
sual acuity worse than
6/ 6
Follow-up: 6 weeks to
18 months
See comment ⊕©©©
Very low1,2,3
Substant ial inconsis-
tency I2 = 54%. Indi-
vidual study RR ranged
f rom 0.2 (95% CI 0.03
to 1.56) to 1.50 (0.63 to
3.59)
Unaided near visual
acuity worse than J3/
J4
Follow-up: 6 weeks to
18 months
570 per 1000 114 per 1000
(40 to 330)
RR 0.20
(0.07 to 0.58)
782
(8 studies)
⊕⊕©©
Low1,3
Substant ial inconsis-
tency I2 = 93% but all in-
dividual study results in
direct ion favouring mul-
t if ocal IOLs. Individual
study RR ranged f rom
0.02 (0.00 to 0.31) to 0.
73 (0.54 to 0.97)
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Spectacle dependence
Follow-up: 6 weeks to
18 months
880 per 1000 554 per 1000 (484 to
642)
RR 0.63
(0.55 to 0.73)
1000
(10 studies)
⊕⊕©©
Low1,4
Substant ial inconsis-
tency I2 = 67% but
all individual study re-
sults favoured mult i-
f ocal IOLs. Individual
study RR ranged f rom
0.35 (0.21 to 0.57) to 0.
79 (0.61 to 1.03)
Participant- re-
ported outcomes: qual-
ity of life or visual func-
tion
See comment - - 435
(4 studies)
⊕©©©
Very low1,2,3
On average most peo-
ple in both groups
achieved high scores
on VF-7/ VF-14 ques-
t ionnaires but incon-
sistent comparat ive re-
sults between the 2
groups
Participant- reported
outcomes: glare
Follow-up: 6 weeks to
18 months
180 per 1000 254 per 1000
(185 to 347)
RR 1.41
(1.03 to 1.93)
544
(7 studies)
⊕⊕©©
Low1,2
-
Participant- reported
outcomes: haloes
Follow-up: 6 weeks to
18 months
80 per 1000 286 per 1000 (159 to
517)
RR 3.58
(1.99 to 6.46)
662
(7 studies)
⊕⊕⊕©
M oderate1
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; IOL: intraocular lens; RR: risk rat io.
GRADE Working Group grades of evidence
High certainty: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate certainty: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low certainty: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low certainty: We are very uncertain about the est imate.
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1 Downgraded for risk of bias (-1): masking of part icipants and outcome assessors dif f icult in these trials; report ing bias
unclear.
2 Downgraded for imprecision (-1): wide conf idence intervals.
3 Downgraded for inconsistency (-1): I2 > 50%.
4 Downgraded for publicat ion bias (-1): asymmetric funnel plot.
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B A C K G R O U N D
Description of the condition
Cataract, defined as the presence of visually impairing lens opacity
in one or both eyes, is present in 30% of people aged 65 years and
over in the UK (Desai 1999). Around 400,000 cataract extractions
were performed in England in the year 2014 to 2015 (Department
of Health 2015).
People with cataract usually present with one or more of the fol-
lowing symptoms: gradual reduction in visual acuity (VA), glare,
change in glasses prescription and change in colour appreciation.
The diagnosis may be made by the person’s general practitioner or
optometrist followed by referral to an ophthalmic surgeon for con-
firmation of the diagnosis and management. Many people with
treatable visual impairment from cataract do not access health ser-
vices (Desai 1999).
Description of the intervention
Cataracts causing only mild symptoms may not need treatment,
while changes in glasses prescription due to cataract may simply
be managed by the provision of new glasses. Where these options
are inadequate the only treatment available is surgical extraction of
the cataract. This is routinely accompanied by implantation of an
intraocular lens (IOL) to replace the focusing power of the natural
lens.
Current techniques of cataract surgery and IOL implantation al-
low accurate prediction of postoperative refraction. Existing stan-
dards of best-corrected postoperative VA (Desai 1993) are being
replaced by an expectation of good uncorrected distance acuity.
This has been driven partly by the change from cataract surgery
using a large (10 mm) incision to small incision (2 mm to 4 mm)
phacoemulsification surgery. This change is generally perceived
to offer greater predictability of refractive outcomes, a necessary
pre-requisite for good VA without the need for glasses. Cochrane
systematic reviews comparing surgical approaches have been pub-
lished (Ang 2012; Riaz 2013; de Silva 2014).
Because standard IOLs have a fixed refractive power the focal
length is also fixed (monofocal). This means that most people will
require a reading addition to their distance glasses prescription
(Javitt 1997).Whilemost people undergoing cataract surgery may
be happy to use reading glasses, a proportion are likely to seek
good unaided near vision as well as distance vision. The need for
reading glasses for near vision is unlikely to be considered an im-
portant issue at present in low-income countries where the burden
of blindness due to cataract is so high.
How the intervention might work
One approach to improve near VA is to modify the IOL. There
are no IOLs currently available that can change shape during ac-
commodation in the manner of the natural crystalline lens. A
fixed-shape optic IOL could theoretically provide near vision if
attempted accommodation resulted in forward displacement of
the IOL. Efforts to design an IOL using this principle have so far
been unsuccessful (Legeais 1999).
An IOL can also provide near and distance vision if both powers
are present within the optical zone. This has been attempted using
diffractive optics or with zones of differing refractive power. Both
types of IOL divide light up to focus at two (bifocal) or more
(multifocal) points so that the person can focus on objects at more
than one distance from them. IOLs of both types are currently
commercially available.
Optical evaluation of multifocal IOLs has been performed in de-
tail. Exact figures vary with the IOL tested but essentially a two-
to three-fold increase in the depth of field is achieved at the ex-
pense of a 50% reduction in the contrast of the retinal image
(Holladay 1990; Lang 1993). Clinical evaluation of a multifo-
cal IOL is less clear-cut. Several large studies, including non-ran-
domised comparisons with monofocal IOLs, have indicated that
the quality of vision with bifocal and multifocal IOLs is good
(Gimbel 1991; Knorz 1993; Lindstrom 1993; Steinert 1999). The
key question to be answered is whether the optical trade-off in-
herent in a multifocal IOL results in better or worse visual func-
tion compared to a monofocal IOL. Objective (Desai 1993) and
subjective (Desai 1996) improvement in vision following cataract
surgery withmonofocal IOL implantation is so high that any study
lacking a randomised control group as a comparator will be rela-
tively uninformative.
Why it is important to do this review
There is an extensive body of published data on both monofocal
and multifocal IOLs describing largely successful outcomes. To
draw some conclusions regarding the relativemerits of the different
IOL types we undertook a systematic review of the best quality
data (that from randomised controlled trials).
O B J E C T I V E S
To assess the visual effects of multifocal IOLs in comparison with
the current standard treatment of monofocal lens implantation.
M E T H O D S
Criteria for considering studies for this review
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Types of studies
We included randomised controlled trials.
Types of participants
We included trials in which participants were undergoing cataract
surgery and IOL implantation in one or both eyes. There were no
restrictions on race, gender or ocular comorbidity.We excluded tri-
als that included participants with paediatric cataract (onset prior
to age 16 years).
Types of interventions
We included trials in which any type of diffractive or refractive
multifocal IOL was compared with monofocal IOL implantation.
In the current update 2016 we considered two comparisons. This
was a protocol amendment (see Differences between protocol and
review for further explanation).
• Multifocal IOLs versus monofocal IOLs.
• Multifocal IOLs versus monovision.
Types of outcome measures
Outcome data were collected at the longest time postoperatively
that was available in each study.
We revised the outcomes for the update in 2016 (see Differences
between protocol and review).
Primary outcomes
• Distance, intermediate and near VA (unaided and
corrected).
◦ We used the cut-point of worse than 6/6 for distance
VA (20/20, logMAR score > 0) as 6/6 vision is usually considered
normal VA. We used the cut-point of worse than J3/J4 (Jaegar
cards) or equivalent for near VA.
◦ We also considered VA as a continuous variable where
it was reported in logMAR units.
• Spectacle dependence as reported by the participant.
Secondary outcomes
• Contrast sensitivity (contrast is the difference between the
brightness of an image and its background divided by the total
brightness of image plus background. Contrast sensitivity is the
inverse of target contrast threshold).
• Participant-reported outcomes including:
◦ quality of life or visual function as measured by
validated instruments;
◦ informal (non-validated) subjective assessment of
visual function;
◦ participant satisfaction;
◦ glare (glare occurs when a light source other than the
target image illuminates the retina, resulting in reduced contrast.
Scatter of light from the glare source by the optics of an IOL
may cause unequal glare between participants);
◦ other optical aberrations including halos.
• Resource use and costs.
Adverse effects
• Any other adverse effects or complications as reported in
trial reports.
Search methods for identification of studies
Electronic searches
We searched CENTRAL (which contains the Cochrane Eyes
and Vision Trials Register) (2016, Issue 5), Ovid MEDLINE,
Ovid MEDLINE In-Process and Other Non-Indexed Citations,
Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946
to June 2016), Embase (January 1980 to June 2016), the IS-
RCTN registry (www.isrctn.com/editAdvancedSearch), Clinical-
Trials.gov (www.clinicaltrials.gov), and the World Health Orga-
nization (WHO) International Clinical Trials Registry Platform
(ICTRP) (www.who.int/ictrp/search/en).We did not use any date
or language restrictions in the electronic searches for trials. We last
searched the electronic databases on 13 June 2016.
See: Appendices for details of search strategies for CENTRAL
(Appendix 1), MEDLINE (Appendix 2), Embase (Appendix 3),
ISRCTN (Appendix 4), ClinicalTrials.gov (Appendix 5) and the
ICTRP (Appendix 6).
Searching other resources
We searched the reference lists of relevant articles and Martin Ley-
land’s personal database of trials. For the first version of the review
we contacted investigators of included studies and themanufactur-
ers of multifocal IOL (Acute Care; Spectrum Ophthalmics; Storz
Ophthalmics; Bausch & Lomb Surgical Ltd (UK); Alcon Labora-
tories Ltd; Pharmacia & Upjohn; Rayner Intraocular Lenses Ltd)
for details of additional published and unpublished trials. We did
not do this for subsequent updates.
Data collection and analysis
Selection of studies
Two review authors working independently examined the titles
and abstracts from the electronic searches. We obtained the full
paper of any trial that appeared to fit the inclusion criteria. We
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assessed full copies according to the definitions in the Criteria for
considering studies for this review. We only assessed trials meeting
these criteria for risk of bias.
Data extraction and management
For the update 2016, partly because we had revised the outcomes
but also because we needed to incorporate more information as
a result of the updated methodological expectations of Cochrane
Reviews (MECIR 2013), we extracted the data for all trials again
using a piloted customised data extraction template in web-based
review management software (Covidence 2016). Review author
pairs extracted data independently (JE/VK/MZ) and a third review
author (SdeS) adjudicated discrepancies as needed. We imported
data directly from Covidence into Review Manager 5 (RevMan
2014), which was checked by one review author (JE).
Assessment of risk of bias in included studies
Review author pairs (JE/VK/MZ) independently assessed risk of
bias in Covidence using Cochrane’s tool for assessing risk of bias
(Higgins 2011) and as outlined in Table 1.
Measures of treatment effect
Our measure of treatment effect was the risk ratio (RR) for di-
chotomous outcomes and mean difference (MD) or standardised
mean difference (SMD) for continuous outcomes, with 95% con-
fidence intervals (CI). The use of the MD was a protocol amend-
ment - see Differences between protocol and review. Where pos-
sible, we checked for skewness using the method outlined in the
Cochrane Handbook for Systematic Reviews of Interventions (Deeks
2011).
Unit of analysis issues
The intervention could be applied to one or both eyes. We have
indicated for each trial whether unilateral or bilateral surgery was
done.
For the unilateral trials, the outcomewasmeasured on the operated
eye. For the bilateral trials, the outcome could be measured and
reported on both eyes, or for the person (i.e. binocular vision).
Where available, we have chosen reported binocular vision for the
analyses. Where data were reported for both eyes, and appropriate
methods of adjustment were not included, we requested further
data from the investigators.
For studies with multiple multifocal treatment groups, we com-
bined data for the different groups using the Review Manager 5
calculator (RevMan 2014).
Dealing with missing data
The analyses in this reviewwere available case analyses. This makes
the assumption that data weremissing at random.We recorded the
amount of missing data and reasons for exclusions and attrition,
where available and documented this in the ’Risk of bias’ table for
each study (Characteristics of included studies table, “incomplete
outcome data”).
Assessment of heterogeneity
We assessed heterogeneity by examining the forest plots to see
whether the direction of effect was similar in all studies and
whether the CIs for the individual study estimates overlapped. To
assess the role of chance we used the Chi2 test, although this may
have low power when there are few studies, or the studies are small.
We also considered the I2 statistic (Higgins 2003). We took an I
2 value of 50% or more to indicate substantial inconsistency in
study results.
Assessment of reporting biases
We assessed publication bias when the meta-analysis included 10
or more trials by plotting effect size against standard error.
Data synthesis
Where three ormore studies contributed to the analyses, we pooled
the data using a random-effects model. If there were fewer than
three studies, we used a fixed-effect model. If there was substantial
heterogeneity or inconsistency (see Assessment of heterogeneity),
we did not report the pooled analyses unless all individual study
estimates were in the same direction.
Subgroup analysis and investigation of heterogeneity
We considered two main sources of heterogeneity: type of lens
(refractive or diffractive) and whether the surgery was unilateral
or bilateral. We compared subgroups using the standard test for
interaction implemented in Review Manager 5 (RevMan 2014).
Sensitivity analysis
We performed a sensitivity analysis excluding studies at high risk
of bias in one or more domains. This was a protocol amendment
(see Differences between protocol and review).
’Summary of findings’ table
We prepared a ’Summary of findings’ table presenting absolute
and RRs with an assessment of the overall quality of the evidence
using GRADE (GRADEpro 2014). We included the following
outcomes in the table.
• Unaided distance VA worse than 6/6.
• Corrected distance VA worse than 6/6.
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• Unaided near VA worse than J3/J4.
• Spectacle dependence.
• Participant-reported outcomes: quality of life or visual
function.
• Participant-reported outcomes: glare.
• Participant-reported outcomes: halos.
R E S U L T S
Description of studies
Results of the search
Original review
The initial electronic searches found 239 titles and abstracts. We
obtained the full copies of possibly relevant papers according to the
criteria specified (see Searchmethods for identification of studies).
One trial did not include a monofocal control group and was
excluded (Walkow 1997). We identified nine papers as meeting
the inclusion criteria for this review.On contacting the authors, we
identified three as descriptions of the same cohort of participants
(Haaskjold 1998a). Interimdatawere available on149participants
with five to six months’ follow-up (Allen 1996), and a subsequent
paper reported corrected distance acuity and contrast sensitivity
data only (with no numerical data for contrast sensitivity) on 221
participants (Haaskjold 1998b). An unpublished report from the
lens manufacturer described limited data on 190 participants at
one year (Pharmacia 1995). The study author was also able to
supply additional unpublished results.
Search updates
Updated searches in May 2002 identified 32 reports of which
two further studies were relevant (Kamlesh 2001; Leyland 2002).
An updated in September 2005 found 218 reports of which two
further studies were relevant (Nijkamp 2004; Sen 2004). One trial
was excluded because it was not randomised (Richter-Mueksch
2002).
An updated search done in March 2012 identified 432 new
records. The Trials Search Co-ordinator scanned the search results
and removed 308 records which were not relevant to the scope
of the review. We assessed the remaining 124 records for poten-
tial inclusion. We rejected a further 100 records and obtained the
full text of 24 records for further assessment. We included six
studies in the review (Cillino 2008; Harman 2008; Palmer 2008;
Zhao 2010; Alio 2011a; Jusufovic 2011). We identified two stud-
ies that were ongoing in 2012 - one of which has now been in-
cluded in the review (Wilkins 2013, ISRCTN37400841) and one
of which has now been excluded (NCT01088282). We excluded
16 studies (Xu 2007; Maxwell 2008; Ortiz 2008; Allen 2009;
Cionni 2009; Hayashi 2009a; Hayashi 2009b; Hayashi 2009c;
Hida 2009; Hayashi 2010; Huang 2010; Shah 2010; Alio 2011a;
Alio 2011b; Ji 2011; Zhang 2011). See Characteristics of excluded
studies table for reasons for exclusion.
To assess the three Chinese studies, we asked Taixiang Wu, who is
a Cochrane author and heads the Chinese Clinical Trials Registry,
to contact the study authors and ask if the studies were randomised
(Xu 2007; Huang 2010; Ji 2011). Taixiang Wu confirmed that
none of the three studies randomised participants to interventions.
We assessed three studies which had previously been awaiting as-
sessment and excluded them from the review (Liang 2005; Rocha
2005; Souza 2006). See Characteristics of excluded studies table
for details of reasons for exclusion.
Update searches ran in June 2016 yielded a further 981 records
(Figure 1). After removing 119 duplicates, the Cochrane Informa-
tion Specialist (CIS) screened the remaining 862 records and re-
moved 670 references which were not relevant to the scope of the
review. We screened the remaining 192 references and obtained
seven full-text reports for further assessment. We included five
reports (Peng 2012; Rasp 2012; Ji 2013; Wilkins 2013; Labiris
2015), and excluded two (Alio 2015; Puell 2015). We checked
the status of the ongoing studies published in the previous ver-
sion of this review and have excluded one study (NCT01088282)
and study ISRCTN37400841 has been completed and included
(Wilkins 2013). We re-assessed one study which was previously
included and have now excluded the study (Alio 2011c).
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Figure 1. Study flow diagram.
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Included studies
Details of the individual trials are summarised in Table 2; infor-
mation on the individual trials are included in the Characteristics
of included studies table.
Design
There were four multicentre and 16 single-centre studies.
Participants
The total number of people enrolled was 2230. Of these people,
2061 (3194 eyes) were followed up andwere included in the analy-
ses. The smallest study randomised 40 people (Kamlesh 2001) and
the largest trial randomised 261 people (Javitt 2000). All studies
recruited people with age-related cataract with no other apparent
ocular morbidity and without excess corneal astigmatism.
Table 3 shows the mean age and sex of people enrolled in these
trials. The median mean age was 69 years and median percentage
women was 57%.
Interventions
The studies considered different types of multifocal lenses includ-
ing refractive (10 studies), diffractive (six studies), mixture of re-
fractive and diffractive lenses (three studies) and one study used
a multifocal lens with both refractive and diffractive properties
(Table 4). Two studies compared the multifocal lens to monovi-
sion (Wilkins 2013; Labiris 2015).
The cataract surgery performed in 16 studies was small inci-
sion phacoemulsification. Three studies employed extracapsular
cataract extraction and one study included both types of surgery.
In 12 studies the cataract surgery was bilateral in all or some people
(participants had the same type of lens inserted into both eyes).
In cataract surgery, the lens capsulemust be breached to gain access
to the crystalline lens. A continuous circular tear (capsulorhexis)
is preferred to the older ’can-opener’ technique using multiple
small tears or incisions because the incidence of postoperative IOL
decentration is likely to be reduced. Decentration leads to induced
astigmatism and a reduction in unaided VA. Most studies used
capsulorhexis and four studies used envelope capsulotomy (el
Maghraby 1992; Percival 1993; Rossetti 1994; Kamlesh 2001).
Outcomes
Distance VAwasmeasured using either Snellen charts (10 studies),
Early Treatment of Diabetic Retinopathy Study charts (ETDRS)
(Rossetti 1994; Leyland 2002; Nijkamp 2004; Harman 2008;
Peng 2012; Wilkins 2013; Labiris 2015) or Regan contrast acuity
charts (Steinert 1992; Javitt 2000). One study did not specify the
chart but reported logMAR VA (Rasp 2012).
Jaeger reading cards were most commonly used to measure near
VA (seven studies); however, other studies used Sloan near acuity
charts (Cillino 2008; Zhao 2010), the De Nederlander Reading
chart (Nijkamp 2004), Bailey-Love logMAR word reading acuity
chart (Leyland 2002;Harman 2008); Rosenbaum near acuity card
(Steinert 1992; Javitt 2000); Snellen chart (Percival 1993; Palmer
2008); and handheld ETDRS near-reading chart (Rossetti 1994;
Peng 2012;Wilkins 2013). Labiris 2015 did not state which chart
was used but this was likely to be ETDRS.
Therewas variety in theway that studies reported distance andnear
acuity. Some trials reported cut-points used in this review (worse
than 6/6, worse than J3/J4), some reported acuity as a continuous
variable and some reported both.
Contrast sensitivity was measured and reported in many ways.
Six studies used the Pelli-Robson chart (Rossetti 1994; Kamlesh
2001; Leyland 2002;Harman 2008;Wilkins 2013; Labiris 2015),
four trials used the Vision Contrast Test System (VCTS) chart
(Haaskjold 1998a; Sen 2004; Cillino 2008; Zhao 2010), two trials
used the Regan Contrast Acuity chart (Steinert 1992; Percival
1993), one trial used the CGT 1000 contrast sensitivity testing
instrument (Ji 2013), and one trial used the Functional Acuity
Contrast Test (FACT) chart in the OPTEC 6500 chart (Palmer
2008). Even trials using the same chart did not report the results
in the same way - the data were described variously as contrast
sensitivity, VA at different contrast levels and difference between
high contrast and lower contrast acuity - and it was difficult to
pool data for contrast sensitivity. Three studies assessed the extent
of glare disability using the Brightness Acuity Tester (Steinert
1992; Leyland 2002; Harman 2008), and most studies elicited
information from participants as to the extent of problems with
glare or haloes (or both).
Some studies formally addressed visual functioning after surgery
using validated instruments such as the VF-7 (Sen 2004; Cillino
2008; Zhao 2010), VF-14 (Nijkamp 2004; Labiris 2015), and
TyPE questionnaire (Javitt 2000; Leyland 2002). Eleven studies
reported participant-reported satisfaction (Steinert 1992; Percival
1993; Rossetti 1994; Haaskjold 1998a; Kamlesh 2001; Sen 2004;
Nijkamp 2004; Cillino 2008; Zhao 2010; Peng 2012; Wilkins
2013).
Follow-up ranged from one month to 18 months.
Data collection and reporting
Near vision and subjective outcomes were poorly assessed and
reported. Only five studies reported both unequivocal unaided
and corrected logMAR near acuity measures (Javitt 2000; Leyland
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2002; Harman 2008; Peng 2012; Rasp 2012). Palmer 2008 re-
ported corrected near vision using Snellen that was converted to
logMAR, and near vision with best distance correction. Only five
studies used validated instruments for subjective outcomes (Javitt
2000; Leyland 2002; Nijkamp 2004; Sen 2004; Zhao 2010).
Financial support
Two studies had no external funding, eight studies did not give
funding details and four studies received some funding frommul-
tifocal IOL manufacturers. Seven studies used other sources of
funding, namely the Saudi Eye Foundation, Hillingdon Hospital
Research and Development Fund, Shanghai Leading Academic
Discipline Project, Eye Research Institute Maastricht, Education
Department of Liaoning Province grants, a Finnish Government
Special Grant and a Finnish Eye Foundation Grant and UK Na-
tional Institute for Health Research Biomedical Research Centre
in Ophthalmology at Moorfields Eye Hospital and UCL Institute
of Ophthalmology funding.
Excluded studies
See Characteristics of excluded studies table.
Risk of bias in included studies
See Figure 2 and Figure 3.
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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We contacted the authors of included papers for further in-
formation on their studies. We received replies clarifying vari-
ous methodological issues for three studies (el Maghraby 1992;
Haaskjold 1998a; Javitt 2000).
Allocation
Eight studies described an adequate method for random se-
quence generation (el Maghraby 1992; Javitt 2000; Nijkamp
2004; Cillino 2008; Zhao 2010; Jusufovic 2011; Wilkins 2013;
Labiris 2015). The other studies did not report any information
on how the sequence was generated but were described as “ran-
domised”.
Seven studies provided a convincing description of allocation con-
cealment (Leyland 2002; Nijkamp 2004; Harman 2008; Cillino
2008; Jusufovic 2011; Peng 2012; Wilkins 2013), and authors for
two studies confirmed allocation concealment (elMaghraby 1992;
Haaskjold 1998a). Two studies were at high risk of allocation bias
because methods of concealment were not clearly reported and
there were baseline imbalances (Kamlesh 2001; Palmer 2008).
Masking (performance bias and detection bias)
Four studies described masking of participants (Steinert 1992;
Javitt 2000; Cillino 2008; Wilkins 2013). In Harman 2008, the
IOL type was disclosed to participants at the three-month visit.
All outcomes for this study have therefore been reported for the
three-month visit prior to the IOL disclosure, except for spectacle
dependence and symptoms of glare/haloes that were only reported
at the 18-month visit. Interestingly, following disclosure of mul-
tifocal IOL status, participants in this group showed an improve-
ment in near vision and spectacle independence by the 18-month
visit.
Several studies mentioned masking but it was not clear how suc-
cessful it had been. In Leyland 2002, participants were informed
that the IOL type implanted would not be revealed to them un-
til completion of the trial but a proportion of participants were
reported to be unmasked; in Palmer 2008, participants were not
told which lens they would receive but it was unclear whether any
of them could have guessed; in Peng 2012, the study was described
as a “prospective, randomised, comparative, and observer-masked
trial” but there was no information on masking in the study re-
port; in Zhao 2010, participants and medical staff collecting data
were masked but there was no information on the staff providing
care.
The remaining studies did not mention masking and we have as-
sumed therefore that it was not done. Labiris 2015 did not de-
scribe masking and on the clinical trials registry was described as
’open label’.
Three studies that were (possibly) not masked successfully to
participants reported masking outcome assessors (Leyland 2002;
Harman 2008; Zhao 2010). In general, studies that masked par-
ticipants and personnel also masked outcome assessors, the excep-
tion being Wilkins 2013.
Incomplete outcome data
We judged attrition bias to be low risk in two studies where reasons
and numbers of participants who exited the study after interven-
tion andbefore outcomeswere clearly reported andwe thought un-
likely to affect the outcome (Peng 2012;Wilkins 2013). Five stud-
ies were at high risk of attrition bias (Steinert 1992; el Maghraby
1992; Percival 1993; Nijkamp 2004; Sen 2004). This was either
due to significant numbers of participants being lost to follow-
up without clear indication of which group they had been ran-
domised to, or exclusion of participants after randomisation based
on outcome such as high astigmatism. However, most studies did
not clearly report follow-up and it was difficult to make a judge-
ment.
Selective reporting
The extent to which selective reporting had occurred for each
individual study was unclear because in general we did not have
access to study protocols. Of studies registered prospectively on a
publicly available database, Labiris 2015 was deemed to have low
reporting bias since all outcomes were reported; for Wilkins 2013,
there were some differences between the trial registry entry and
outcomes reported.
Effects of interventions
See: Summary of findings for the main comparisonMultifocal
compared to monofocal intraocular lenses after cataract extraction
The lenses used in each study are detailed in Table 4 and refrac-
tive aims are summarised in Table 5. Five studies compared two
(el Maghraby 1992; Leyland 2002), three (Cillino 2008; Palmer
2008), or four (Rasp 2012) differentmultifocal IOLswith amono-
focal control group. The multifocal IOL results within these stud-
ies were similar and therefore we have pooled them for this review.
Two studies compared multifocal with monovision and are con-
sidered separately (Wilkins 2013; Labiris 2015).
Multifocal versus monofocal lenses
Primary outcomes
Distance visual acuity
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Eight studies reported the number of participants who did not
achieve an unaided VA of 6/6 (n = 682) (Analysis 1.1). These
tended to be older studies (Steinert 1992; el Maghraby 1992;
Percival 1993; Rossetti 1994;Haaskjold 1998a; Leyland 2002; Sen
2004; Jusufovic 2011). There was little evidence for any important
difference between the two groups with a pooled risk ratio (RR)
0.96, 95% confidence interval (CI) 0.89 to 1.03). We judged this
to be moderate-certainty evidence, downgrading one level for risk
of bias (Summary of findings for the main comparison).
Six studies reported mean unaided logMAR VA (n = 848) (Anal-
ysis 1.2). There was substantial inconsistency (I2 = 74%) but in
all studies the mean difference between groups was less than 0.1
logMAR.
Eight studies reported the number of participants that did not
achieve a corrected VA of 6/6 (n = 692) (Analysis 1.3). Again these
studies were older, all being conducted no later than 2004. There
was inconsistency (i2=54%) possibly reflecting changes over time
in lenses used. The individual study estimates ranged from RR
0.20 (95% CI 0.03 to 1.56) (Kamlesh 2001) in favour of multifo-
cal lenses to 1.50 (0.63 to 3.59) (Percival 1993) in favour of mono-
focal lenses. We judged this to be very low-certainty evidence,
downgrading one level for risk of bias, one level for imprecision
due to the wide CIs and one level for inconsistency. (Summary of
findings for the main comparison).
Six studies reported mean corrected logMAR VA (n = 848) (Anal-
ysis 1.4). There was no evidence for any major difference between
groups with all studies reporting a mean difference of 0.1 logMAR
or less but again with substantial inconsistency (I2 = 64%).
Intermediate visual acuity
One study reported intermediate VA (Analysis 1.5). Mean un-
aided logMAR VA was 0.17 (standard deviation (SD) 0.15) in the
multifocal group (n = 100) and 0.27 (SD 0.15) in the monofocal
group (n = 102). The MD was therefore small at -0.10 logMAR
(95% CI -0.14 to -0.06). Mean corrected logMAR intermediate
VA was similar at 0.16 (SD 0.11) in the multifocal group and
0.24 (SD 0.11) in the monofocal group, with a small difference
between groups (MD -0.08 logMAR, 95% CI -0.11 to -0.05).
Near visual acuity
Eight studies reported unaided near VA of worse than J3/J4 or
equivalent (n = 782) (Analysis 1.6). There was significant hetero-
geneity in the method used for near VA measurement which may
affect the accuracy of pooled outcomes. People receiving a multi-
focal lens were less likely to have poor near vision (RR 0.20, 95%
CI 0.07 to 0.58). We judged the evidence to be of low-certainty.
We downgraded one level for risk of bias and one level for incon-
sistency between studies (I2 = 93%). The RRs ranged from 0.02
(Jusufovic 2011) to 0.73 (Leyland 2002) in the individual studies
(Summary of findings for the main comparison).
Five studies reported mean unaided near VA (n = 829) (Analysis
1.7). There was substantial inconsistency between studies (I2 =
98%) but all studies favoured the multifocal group.
Four studies reported corrected near VAworse than J3/J4 or equiv-
alent (n = 344) (Analysis 1.8). There were better outcomes in the
multifocal group (RR 0.32, 95% CI 0.08 to 1.27, I2 = 18%).
Six studies reported mean corrected near VA (n = 1003) (Analysis
1.9). There was substantial inconsistency (I2=99%). Four studies
reported similar VA in both groups with a mean difference of
less than or equal to 0.1 logMAR (Harman 2008; Javitt 2000;
Palmer 2008; Rasp 2012). One study documented slightly better
corrected near VA in the monofocal group (Leyland 2002) and
one study reported substantially better corrected near VA in the
multifocal group (Rasp 2012).
Spectacle dependence
Ten studies (n = 1000) reported the outcome of spectacle depen-
dence for distance or near vision (Analysis 1.11). Fewer partici-
pants in themultifocal groupwere spectacle dependent in themul-
tifocal compared with the monofocal group (RR 0.63, 95% CI
0.55 to 0.73). There was substantial heterogeneity between studies
(I2 = 67%) but all studies favoured multifocal IOLs. Since there
were data from 10 studies for this outcome, we produced a funnel
plot to evaluate publication bias as planned in our protocol. This
showed evidence of publication bias with a skewed pattern (Figure
4). We downgraded the evidence for spectacle independence one
level for risk of bias and one level for publication bias. We did not
additionally downgrade for inconsistency (Summary of findings
for the main comparison).
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Figure 4. Funnel plot of comparison: 1 Multifocal versus monofocal intraocular lenses, outcome: 1.10
Spectacle dependence (any).
Four studies reported spectacle dependence for distance vision (n
= 618) which overall was reduced in the multifocal group (RR
0.71, 95% CI 0.46 to 1.09) (Analysis 1.11). However, there was
some inconsistency between studies with two studies showing no
overall difference and with the other two studies in favour of the
multifocal group (I2 = 67%).
Six studies reported spectacle dependence for near vision (n =
772) (Analysis 1.11). Fewer participants in the multifocal group
required spectacles for near vision (RR0.53, 95%CI 0.40 to 0.71).
Again there was wide variation between studies (I2 = 85%) but all
had better outcomes in the multifocal group.
Secondary outcomes
Contrast sensitivity
Thirteen studies measured contrast sensitivity; however, they used
several differentmethods (see ’Outcomes’ of Included studies) and
therefore combined analysis of results was difficult. We pooled
and analysed data from four trials (n = 288) that used the Pelli-
Robson chart (Analysis 1.12). This indicated little evidence of any
important difference in contrast sensitivity between groups (MD
-0.09, 95% CI -0.26 to 0.08).
The remaining studies reported poorer contrast sensitivity out-
comes in the multifocal group. One study reported a small
difference in contrast sensitivity in participants with good VA
(Haaskjold 1998a); three studies reported contrast sensitivity at
a particular spatial frequency (Cillino 2008; Palmer 2008; Zhao
2010), and four studies reported overall poorer contrast sensitivity
in the multifocal group (Steinert 1992; Percival 1993; Kamlesh
2001; Ji 2013).
Participant-reported outcomes: visual function and quality
of life
Four studies reported results of visual function questionnaires (n =
480) (Analysis 1.13). There was some evidence of more favourable
outcomes in themultifocal group, however the size of the effectwas
small and uncertain due to wide CIs and there was inconsistency
between studies such that a pooled result may not be meaningful.
(I2 = 92%).
Only one study assessed vision-related quality of life and found no
difference between multifocal or monofocal IOL groups (Analysis
1.14).
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Participant-reported outcomes: satisfaction
Six studies reported satisfaction scores (n = 643). The difference
between groups was uncertain due to inconsistency between stud-
ies (I2 = 88%) (Analysis 1.15).
Four studies reported the number of participants that reported
having ’good’ vision or being ’satisfied’ with their overall vision
(n = 388). There was no evidence of any important differences
between groups (RR 0.99, 95% CI 0.92 to 1.06) (Analysis 1.16).
One study assessed participant satisfaction for near vision (n =
80) and found a greater number of participants reporting good
outcomes in the multifocal IOL group (RR 1.42, 95% CI 1.13 to
1.78) (Analysis 1.16) (Rossetti 1994). The same study also assessed
participant satisfaction for distance vision with a slightly greater
level of satisfaction in the monofocal group (RR 0.89, 95% CI
0.72 to 1.10) (Analysis 1.16).
One study assessed visual satisfaction at 12months using the TyPE
questionnaire and found no difference between groups (Analysis
1.17) (Leyland 2002).
Participant-reported outcomes: visual symptoms
Cataract symptom scores
Two studies with 257 participants reported cataract symptom
scores (Analysis 1.18). Both studies used the Cataract Symptom
Score (CSS) (Steinberg 1994). Nijkamp 2004 reported final value
at 3 months, Sen 2004 reported change between surgery and 1
month.
The CSS requires participants to reported whether they are both-
ered by any of five symptoms: double or distorted vision; seeing
glare, halo, or rings around light; blurry vision; colours looking
different than they used to in a way that is disturbing; and wors-
ening of vision within the past month. A score was given for each
symptom: 0 = “no symptom or not bothered”; 1=“a little both-
ered”; 2 = “somewhat bothered”; and 3 = “very bothered”. A to-
tal score of 15 was possible ranging from 0 (no symptoms or not
bothered by any of the symptoms) to 15 (very bothered by all five
symptoms). On average people in the multifocal group had worse
symptom scores (MD 1.01 score, 95% CI 0.39 to 1.64; I2 = 0%).
Glare
Seven studies (n = 544) assessed postoperative glare. More people
in the multifocal group reported problems with glare: (RR 1.41,
95% CI 1.03 to 1.93) (Analysis 1.19). We judged this to be low-
certainty evidence downgrading one level for risk of bias and one
level for imprecision as the lower CI was close to 1 (Summary of
findings for the main comparison).
Haloes
Seven studies (n = 662) questioned participants regarding post-
operative haloes. More people in the multifocal group reported
haloes (RR 3.58, 95%CI 1.99 to 6.46) (Analysis 1.20).We judged
this to be moderate-certainty evidence downgrading one level for
risk of bias (Summary of findings for the main comparison).
Dysphotopsia
One study reported postoperative dysphotopsia (n = 114). There
were more people with dysphotopsia in themultifocal group com-
pared with the monofocal group (RR 1.18, 95% CI 0.76 to 1.82)
(Analysis 1.21).
Complications
Complications of surgery can be expected to be similar for multi-
focal and monofocal IOLs as the lenses are similar in all but the
design of the optics and require no modifications to surgical tech-
nique. Ten studies reported perioperative and postoperative com-
plications (el Maghraby 1992; Percival 1993; Javitt 2000; Leyland
2002; Sen 2004; Nijkamp 2004; Cillino 2008; Harman 2008;
Zhao 2010; Peng 2012). The incidence of complications was low
and similar in the multifocal and monofocal groups.
Subgroup analyses
We did two subgroup analyses: refractive lenses versus diffractive
lenses (Table 6) and bilateral surgery versus unilateral surgery (
Table 7).
These analyses must be interpreted with caution due to the small
numbers of studies in each group which means the test for inter-
action may have low power and the large number of outcomes
which may lead to spurious findings.
Comparing diffractive and refractive lenses, there was some in-
dication that the diffractive lenses performed better. Specifically
diffractive lenses had better visual function questionnaire scores
and better satisfaction scores, and lower spectacle dependence.
The comparison between bilateral and unilateral surgery was dif-
ficult to interpret. There were two outcomes that had a significant
P value for interaction, corrected distance VA worse than 6/6 and
visual function scores, but in both these cases there was only one
trial in some of the subgroups so it is difficult to attribute the
difference in effect solely to this characteristic.
Sensitivity analysis
We excluded studies at high risk of bias in one or more domain as
planned in our protocol (Table 8). There were some differences in
outcome but these were not consistent and, due to the relatively
high proportion of trials at high risk of bias, it is difficult to inter-
pret these comparisons due to increased imprecision.
18Multifocal versus monofocal intraocular lenses after cataract extraction (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Multifocal lenses versus monovision
Two studies comparedmultifocal lenses withmonovision (Wilkins
2013; Labiris 2015).
In Wilkins 2013, the investigators enrolled 212 people who re-
ceived bilateral sequential cataract surgery either to receive bilateral
Tecnis ZM900 diffractive multifocal lenses or Akreos AO mono-
focal lenses with the powers adjusted to target -1.25 D monovi-
sion. The participants were followed up to four months and 187
(88%) were seen at that point.
In Labiris 2015, the investigators enrolled 75 people who received
bilateral cataract surgery either to receive bilateral Isert PY60MV
refractive multifocal lenses or SN60WFmonofocal lenses with the
powers adjusted to target -1.25 D monovision. The participants
were followed up to six months. Follow-up was unclearly reported
but the impression was given that all 75 participants were followed
up.
There was no evidence for any important difference in distance
VA between the two groups (MD 0.02 logMAR, 95% CI -0.02
to 0.06; n = 186; studies = 1) (Analysis 2.1) (Wilkins 2013). The
outcome was similar in Labiris 2015, which reported decimal VA
and showed similar distance VA in the two groups.
People receivingmultifocal lenses had similar or very slightly worse
unaided intermediate VA compared with people receiving mono-
vision (MD 0.07 logMAR, 95% CI 0.04 to 0.10; n = 181; studies
= 1) (Analysis 2.1).
People receiving multifocal lenses had similar unaided near VA
compared with people receivingmonovision (MD -0.04 logMAR,
95%CI -0.08 to -0.00; n =186; studies = 1) (Analysis 2.1)Thiswas
supported by Labiris 2015 which reported decimal VA and showed
no significant difference in near VA between the two groups.
People receiving multifocal lenses were less likely to be specta-
cle dependent compared with people with monovision (RR 0.40,
95%CI 0.30 to 0.53; n = 262; studies = 2; I2 = 0%) (Analysis 2.2).
Only Labiris 2015 reported these separately according to near and
distance vision, with people receiving multifocal lenses being less
likely to be spectacle dependent for near vision. There was little
evidence of any effect on spectacle dependence for distance vision
(Analysis 2.2).
Contrast sensitivity wasmarginally better in themonovision group
(MD -0.06, 95% CI -0.10 to -0.02) in Wilkins 2013, but there
was little evidence for any difference in Labiris 2015 (I2 = 67%,
data not pooled) (Analysis 2.3).
People receiving multifocal lenses were more likely to report glare
compared to people receiving monovision (RR 1.41, 95%CI 1.14
to 1.73; n = 187; studies = 1) (Analysis 2.5). This was supported
by data from Labiris 2015, which reported glare and “unwanted
shadows” on a 4-point Likert scale. There were higher mean scores
in the multifocal group for both glare (MD 0.15, 95% CI -0.00
to 0.30; n = 75; studies = 1) and shadows (MD 0.36, 95% CI 0.07
to 0.65; n = 75; studies = 1).
Wilkins 2013 reported IOL exchange. Quote “In the first postop-
erative year, 6 patients (5.7%) in the multifocal group underwent
IOL exchange (4 had a bilateral and 2 had a unilateral exchange).
No patients in the monovision group underwent IOL exchange.”
D I S C U S S I O N
Summary of main results
The results are summarised in Summary of findings for the main
comparison. Distance VA was similar in themultifocal and mono-
focal groups but people with multifocal lenses achieved better near
vision overall and were less dependent on spectacles. Adverse sub-
jective visual phenomena, particularly haloes, were common and
troublesome in people receiving multifocal IOLs.
There was some evidence that contrast sensitivity may be lower
in people receiving multifocal IOLs. The differences were smaller
thanwould be expected given the division of light betweendistance
and near focus, which may result from visual processing. Whether
the reduction in contrast sensitivity induced by the IOL would be
clinically significant would depend on the contrast presented by
the visual target and the contrast sensitivity of the person’s retina.
There were no significant differences between IOLs with respect
to objective glare.
Participant satisfaction was not consistently reported between the
two lens types. There was some evidence that participants with
multifocal lenses experienced improved visual functioning for
tasks requiring near vision compared to participants with mono-
focal lenses.
There was less evidence available for the comparison betweenmul-
tifocal lenses and monovision. The data available suggested simi-
lar distance and better near VA in the multifocal and monovision
groups. Multifocal lenses were associated with less spectacle de-
pendence but also an increased chance of experiencing glare and
haloes compared with monovision.
Overall completeness and applicability of
evidence
Ten of the 20 included studies involved participants with surgery
on both eyes and two studies had a mixture of both unilateral and
bilateral surgery. Unilateral studies allow measurement of unioc-
ular outcomes such as VA but are of limited use when attempting
to measure the effect of the multifocal IOLs on quality of life,
especially where the fellow eye has good vision. Of the studies
that involved unilateral surgery only, Steinert 1992 and Rossetti
1994 reported fellow eye vision as good, Percival 1993 described
the fellow eyes as cataractous and Jusufovic 2011 and Zhao 2010
commented that participants had no prior ocular surgery suggest-
ing a phakic status in the other eye. The other studies involving
unilateral surgery and the two studies that performed surgery on
one or both eyes did not comment on the status of the fellow eye.
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Wepresented results as a combined group of refractive and diffrac-
tive IOL studies. Combination of data was valid as both IOL types
use the same principle of simultaneous vision once incident light
has been split by either the refractive or diffractive optic. Holladay
1990 found very similar optical properties of all multifocal IOLs
tested including the Array refractive IOLs and the 3M diffractive
IOL used in some of the studies reviewed here (the Pharmacia
diffractive IOL is of a similar design to the 3M IOL).We presented
separated data, which are likely to become more useful as further
studies are published.
Unaided near vision is critical to assessment of multifocal efficacy
but was reported in amanner thatmade comparison between stud-
ies difficult. Only eight studies reported unaided near VA worse
than J3/J4 or equivalent, and five studies reported mean LogMAR
unaided near VA allowing pooled data analysis. Furthermore, only
seven studies reported both unaided and corrected near acuity and
Palmer 2008 reported corrected near acuity together with unaided
near acuity but wearing a distance correction. Reading distances
differed in the individual studies and it was unclear in most stud-
ies whether the reported print size read had been corrected for
reading distance to allow a near acuity to be calculated. A further
problem arose because Jaeger cards are not standardised between
manufacturers so that J3 from one study cannot be assumed to
equal J3 from another (Bailey 1978). Despite these caveats, it is
likely that unaided near vision is improved by a multifocal IOL.
It is important to remember, however, that monofocal IOL near
acuity can be restored using reading glasses.
This review has highlighted the need for a core set of outcome
measures in trials comparing multifocal and monofocal lenses.
Ideally these outcomes should be based on validated measures,
particularly for the more subjective outcome measures.
The optical and visual effects of these IOLs are now well-known,
particularly near vision. The search for alternative strategies to
achieve spectacle independence, such as monovision and accom-
modating IOLs, should continue.
Quality of the evidence
We graded the certainty of the evidence as low to moderate for
those outcomes for which we could estimate an effect (Summary
of findings for the main comparison). In general, we downgraded
results for risk of bias because it was difficult to mask participants
and outcome assessors in these trials and difficult to assess report-
ing bias. There was substantial methodological and statistical het-
erogeneity for some outcomes, in particular for the measurement
of corrected distance VA and both unaided and corrected near VA,
as well as participant-reported spectacle dependence. There was
also some evidence of publication bias with respect to the outcome
of spectacle dependence.
Agreements and disagreements with other
studies or reviews
One meta-analysis of outcomes of multifocal IOLs that included
both randomised controlled trials and studies of other design
found slightly better uncorrected distance VA in the monofocal
groups but better uncorrected near VA and greater spectacle in-
dependence in the multifocal group, the latter being similar to
the results from our analysis (Cochener 2011). They also reported
better near VA using diffractive (rather than refractive) multifocal
IOLs, which is similar to the outcomes we found albeit with small
numbers used for analysis. de Vries and colleagues conducted a
review including both randomised controlled trials and case series
(de Vries 2013). This was a narrative review summarising the out-
comes of included studies but did not draw any definitive con-
clusions regarding outcomes that could be compared with results
presented in this systematic Cochrane Review.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Multifocal intraocular lenses may result in better near vision with-
out any adverse effect on distance acuity. Spectacle dependence is
less likely with use of these intraocular lenses when compared to
the standard practice of monofocal implantation.
Whether the improvement in unaided near vision and increased
incidence of spectacle independence are sufficient to outweigh the
experience of glare and haloes is amatter for each person to decide.
The final choice is likely to depend on a person’s motivation to be
free of spectacles, guided by realistic expectations as to the likeli-
hood of achieving this aim and understanding of the compromises
involved.
Implications for research
This review has highlighted the need for a core set of outcome
measures in trials comparing multifocal and monofocal lenses.
Standardised outcome reporting for visual acuity is required to
be able to pool data and draw robust conclusions. Ideally these
outcomes should be based on validated measures, particularly for
the more subjective outcomes, and include the views of people
who have had cataract surgery.
The search for alternative strategies to achieve spectacle indepen-
dence, such as monovision, trifocal and accommodating intraoc-
ular lenses, should continue.
A C K N OW L E D G E M E N T S
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cillino 2008
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal 1: Array SA40N, AMO
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 16 (32)
• Mean age in years (range): 57
• % female: 56
• Ethnic group: NR
Multifocal 2: ReZoom, AMO
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 15 (30)
• Mean age in years (range): 65
• % female: 47
• Ethnic group: NR
Multifocal 3: Tecnis ZM900, AMO
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 16 (32)
• Mean age in years (range): 60
• % female: 63
• Ethnic group: NR
Monofocal: AR40, AMO
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 15 (30)
• Mean age in years (range): 68
• % female: 47
• Ethnic group: NR
Inclusion criteria: bilateral juvenile or senile cataract; visually significant (i.e. Snellen
VA less than 20/30) in ≥ 1 eye; corneal astigmatism not > 1.0 D; and capability of
understanding and signing the informed consent
Exclusion criteria: aged < 21 years; precataract myopia or hyperopia > 3 D; history of
amblyopia; fundus abnormalities that could cause significant vision impairment; previ-
ous surgical intraocular procedures; and ocular comorbidities, such as previous trauma,
glaucoma, diabetic retinopathy, pseudoexfoliation syndrome, chronic uveitis, corneal
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Cillino 2008 (Continued)
opacities, senile miosis or hyporeactive pupil, or alpha-antagonist (tamsulosin) treat-
ment, which might induce floppy iris syndrome. Intraoperative exclusion criteria were
iris pupillary trauma; vitreous loss; and inability to place the IOL in the capsular bag
Pretreatment: there were no significant intergroup differences in age, sex and preoper-
ative SE
Interventions Intervention characteristics
Multifocal 1
• Name of lens: Array SA40N, AMO
• Type of lens: refractive
• Target: emmetropia
Multifocal 2
• Name of lens: ReZoom, AMO
• Type of lens: refractive
• Target: emmetropia
Multifocal 3
• Name of lens: Tecnis ZM900, AMO
• Type of lens: diffractive
• Target: emmetropia
Monofocal
• Name of lens: AR40, AMO
• Type of lens: NA
• Target: emmetropia
Both eyes operated
Outcomes Outcomes: distance, near and intermediate VA; defocusing curves; contrast sensitivity;
participant satisfaction and spectacle independence
Eyes: outcomes measured by eye, unclear number of eyes reported (we have assumed
both eyes reported without adjustment for within-person correlation)
Maximum follow-up: 12 months
Notes Sponsorship source: NR
Declaration of interest: “The authors have no proprietary or commercial interest in any
materials discussed in this article.”
Country: Italy
Setting: eye hospital
Date study conducted: January 2005 to January 2006
Trial registration ID number: NR
Author’s name: Salvatore Cillino
Institution: University of Palermo
Email: cillino@unipa.it
Address: Dipartimento di Neuroscienze Cliniche, Sezione di Oftalmologia, Università
di Palermo, Italy, Via Liborio Giuffrè, n. 13-90127, Palermo, Italy
Risk of bias
Bias Authors’ judgement Support for judgement
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Cillino 2008 (Continued)
Sequence generation Low risk Quote: “Randomization used a 1:1:1:1
block randomization scheme generated by
SPSS statistical software for Windows (ver-
sion 14.0, SPSS Inc, Chicago, IL).”
Allocation concealment Low risk Quote: “The randomization code was
maintained only at the central data facility
and was not broken until all data analysis
was complete.”
Blinding of participants and personnel
All outcomes
Low risk Quote: “The patients and the medical staff
who collected functional data and quality-
of-life data were masked to the type of lens
that each patient received.”
Judgement comment: not possible to mask
the operating surgeon but we judged that
thiswouldnot have important effect on risk
of bias
Blinding of outcome assessors
All outcomes
Low risk Quote: “The patients and the medical staff
who collected functional data and quality-
of-life data were masked to the type of lens
that each patient received.”
Judgement comment: outcome assessors
were masked.
Incomplete outcome data
All outcomes
Unclear risk Quote: “Four patients withdrew after ran-
domization or during the postoperative pe-
riod. Two patients were excluded from the
analysis because of the presence of capsular
brosis at 1 week postoperatively.”
Judgement comment: 91% of participants
followed up but some exclusions after ran-
domisation and unclear which group these
were in
Selective outcome reporting Unclear risk Judgement comment: no protocol or trials
registry entry.
el Maghraby 1992
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal: 815LE, 3M Vision Care
• Number of people (eyes) randomised: 39 (39)
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el Maghraby 1992 (Continued)
• Number of people (eyes) excluded after randomisation: 4 (4)
• Number of people (eyes) lost to follow-up: 1 (1)
• Number of people (eyes) analysed (at longest time point): 28 (28)
• Mean age in years (range): 57 (45 to 90)
• % female: 59
• Ethnic group: NR
Monofocal: 15LE, 3M Vision Care
• Number of people (eyes) randomised: 38 (38)
• Number of people (eyes) excluded after randomisation: 0 (0)
• Number of people (eyes) lost to follow-up: 2 (2)
• Number of people (eyes) analysed (at longest time point): 33 (33)
• Mean age in years (range): 56 (45 to 70)
• % female: 47
• Ethnic group: NR
Inclusion criteria: candidates for cataract extraction by phacoemulsification and IOL
to be implanted was within the range of +17:00 to +23:00 D for emmetropia
Exclusion criteria: evidence or history of uveitis; active progressive corneal disease;
history of previous intraocular surgery in the eye to be studies; intraocular pressure >
23 mmHg or on glaucoma medication; diabetic retinopathy; macular degeneration;
amblyopia or any other known disease that would decrease postoperative BCVA to worse
than 20/40; non age-related cataracts; blind in contralateral eye
Pretreatment: similar characteristics except for more women (59%) in multifocal com-
pared to monofocal group (47%)
Interventions Intervention characteristics
Multifocal:
• Name of lens: 815LE, 3M Vision Care
• Type of lens: diffractive
• Target: emmetropia
Monofocal
• Name of lens: 15LE, 3M Vision Care
• Type of lens: NA
• Target: emmetropia
1 eye operated
Outcomes Outcomes: distance and near VA, refractive error
Eyes: study eye (1 eye operated per person)
Maximum follow-up: 2 to 4 months
Notes Sponsorship source: Saudi Eye Foundation
Declaration of interest: NR
Country: Saudi Arabia
Setting: eye hospital
Date study conducted: NR
Trial registration ID number: NR
Author’s name: Akef El-Magharby
Institution: El-Maghraby Eye Hospital
Email: NR
Address:El-Maghraby EyeHospital, Jeddah, Saudi Arabia, POBox 7344, Jeddah 21462,
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el Maghraby 1992 (Continued)
Saudi Arabia
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Low risk Judgement comment: “Randomization
schedules were generated using Prodas, a
statistical software package.”
Allocation concealment Low risk Judgement comment: NR but confirmed
by author correspondence
Blinding of participants and personnel
All outcomes
High risk Judgement comment: masking NR and
lenses different.
Blinding of outcome assessors
All outcomes
High risk Judgement comment: masking NR and
lenses different.
Incomplete outcome data
All outcomes
High risk Judgement comment: some exclusions after
randomisation 4/39 in multifocal group, 1
of these due to PCO, 1 due to high astigma-
tism and 2 due to pre-existing maculopa-
thy.Overall follow-up at 2 to 4months was
28/39 (71%) for multifocal group and 33/
38 (87%) for monofocal group
Selective outcome reporting Unclear risk Judgement comment: no access to trial reg-
istry entry or protocol
Haaskjold 1998a
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: yes
Participants Baseline characteristics
Multifocal: 808X, Pharmacia Ophthalmics
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 115 (115)
• Mean age in years: 67 (maximum age 88)
• % female: NR
• Ethnic group: NR
Monofocal: 808D, Pharmacia Ophthalmics
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
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Haaskjold 1998a (Continued)
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 106 (106)
• Mean age in years: 67 (maximum age 90)
• % female: NR
• Ethnic group: NR
Inclusion criteria: age-related uncomplicated cataracts, aged ≥ 47 years; preoperative
astigmatism < 1.5 D
Exclusion criteria: eye pathology other than cataract
Pretreatment: not described
Interventions Intervention characteristics
Multifocal
• Name of lens: 808X, Pharmacia Ophthalmics
• Type of lens: diffractive, bifocal
• Target: NR
Monofocal
• Name of lens: 808D, Pharmacia Ophthalmics
• Type of lens: NA
• Target: NR
1 eye operated
Outcomes Outcomes: distance and near VA, contrast sensitivity, participant satisfaction, spectacle
independence and adverse effects (halos, glare etc.)
Eyes: study eye (1 eye operated per person)
Maximum follow-up: 5 months
Notes Sponsorship source: NR
Declaration of interest: NR
Country: Europe (UK, Finland, Germany, Norway, Portugal, Sweden)
Setting: eye hospital
Date study conducted: NR
Trial registration ID number: NR
Author’s name: Erling Haaskjold
Institution: National Hospital, Oslo
Email: NR
Address: Sognsvannsveien 20, 0372 Oslo, Norway
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Unclear risk Judgement comment: study was described
as “randomised” but no further details
given
Allocation concealment Low risk Judgement comment: NR but confirmed
by author correspondence
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Haaskjold 1998a (Continued)
Blinding of participants and personnel
All outcomes
High risk Judgement comment: study was described
as “open”. No information on masking
Blinding of outcome assessors
All outcomes
High risk Judgement comment: study was described
as “open” No information on masking
Incomplete outcome data
All outcomes
Unclear risk Judgement comment: follow-up not clearly
described.
Selective outcome reporting Unclear risk Judgement comment: no access to study
protocol or trials register entry
Harman 2008
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal: Array SA40N, AMO
• Number of people (eyes) randomised: 30 (60)
• Number of people (eyes) excluded after randomisation: 3 (6)
• Number of people (eyes) lost to follow-up: 3 (6)
• Number of people (eyes) analysed (at longest time point): 24 (48)
• Mean age in years: 73
• % female: 50
• Ethnic group:
Monofocal: Clariflex, AMO
• Number of people (eyes) randomised: 30 (60)
• Number of people (eyes) excluded after randomisation: 2 (4)
• Number of people (eyes) lost to follow-up: 9 (18)
• Number of people (eyes) analysed (at longest time point): 19 (38)
• Mean age in years: 71
• % female: 60
• Ethnic group: NR
Inclusion criteria: aged > 21 years; bilateral visually significant cataract; axial length <
25 mm
Exclusion criteria: mature cataract; anterior segment pathology such as pseudoexfoli-
ation or zonular dialysis; previous ocular surgery and any ocular pathology that might
limit the postoperative VA to less than 6/9 (e.g. amblyopia, corneal opacity, macular
disease; preoperative corneal astigmatism of > 2 D in either eye
Pretreatment: baseline comparison of age, gender, logMAR acuity and refractive error.
Multifocal group had lower average spherical equivalent and higher average cylinder
Interventions Intervention characteristics
Multifocal
• Name of lens: Array SA40N, AMO
• Type of lens: refractive
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Harman 2008 (Continued)
• Target: emmetropia
Monofocal
• Name of lens: Clariflex, AMO
• Type of lens: NA
• Target: emmetropia
Both eyes operated
There was a third treatment group in this study that was not included in this review
(accommodative lenses, 1CU)
Quote: “Patients who had >1 D (and <2 D) of corneal astigmatism also underwent
limbus-relaxing incisions (LRIs), using the modified Gills nomogram (21) at the time
of surgery, aiming for postoperative astigmatism of <1 D.”
Quote: “Ten patients required LRIs at the time of surgery: 5 from the 1CU group [not
included in this review], 3 from the multifocal, and 2 from the monofocal. Of these,
only 1 patient from the multifocal group required bilateral LRIs.”
Outcomes Note: participants were asked to practice reading every day without spectacle correction
until 3 months
Outcomes: distance and near VA, refraction, contrast sensitivity, accommodation (defo-
cus, near point), spectacle independence, reading ability and adverse effects (halos, glare,
etc.)
Eyes: both eyes operated, binocular outcomes reported except for refraction and glare
disability (right eye only)
Maximum follow-up: 18 months
Notes Sponsorship source:Hillingdon Hospital Research and Development Fund, Uxbridge,
UK
Declaration of interest: “No author has any conflict of interest with the products
investigated.”
Country: UK
Setting: eye hospital
Date study conducted: NR
Trial registration ID number: NR
Author’s name: Fran Harman
Institution: Ophthalmology Department, Hillingdon Hospital
Email: harmanfran@hotmail.com
Address: Ophthalmology Department, Hillingdon Hospital, Pield Heath Road,
Uxbridge, Middlesex, UB8 3NN, UK
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Unclear risk Judgement comment: participants were
randomly allocated to 1 of the 3 types of
lenses by sealed envelopes opened on the
day of surgery; they received the same IOL
in each eye, and the second eye was op-
erated on within 6 weeks of the first. Se-
quence generation NR
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Harman 2008 (Continued)
Allocation concealment Low risk Judgement comment: participants were
randomly allocated to 1 of the 3 types of
lenses by sealed envelopes opened on the
day of surgery; they received the same IOL
in each eye, and the second eye was oper-
ated on within 6 weeks of the first
Blinding of participants and personnel
All outcomes
High risk Judgement comment: participants were
masked as to the nature of the IOL in-
serted until the 3-month review, and all
were asked to practice reading every day
without spectacle correctionuntil this time.
Participants were not masked for the 18-
month visit
Blinding of outcome assessors
All outcomes
Low risk Judgement comment: all examiners were
masked at the 3- and 18-month reviews.
A subjective masked assessment was made
of PCO in the right eye at the 18-month
review, graded as none, mild, moderate or
severe
Incomplete outcome data
All outcomes
Unclear risk Quote: “Of the 90 patients entering the
trial, 82 completed follow-up at 3 months;
withdrawals were all before second-eye
surgery (development of subretinal neo-
vascular membranes, n 2; cystoid macu-
lar edema, 2; corneal decompensation sec-
ondary to undiagnosed Fuchs’ endothelial
dystrophy, 1; severe local allergic reaction
to preoperative tropicamide drops, 1; IOL
selection error, 1; anterior capsule tear at
time of surgery, 1). Two patients withdrew
from the 1CU group and 3 from each of
the other groups. There were no cases of a
posterior capsule tear or vitreous loss. A fur-
ther 18 patients were lost to follow-up by
18 months (data from these patients were
included in the 3-month results), with 21
patients remaining in the 1CU group, 24
in the multifocal, and 19 in themonofocal.
”
Selective outcome reporting Unclear risk Judgement comment: no access to study
protocol or trials register entry
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Javitt 2000
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: yes
Participants Baseline characteristics
Multifocal: Array SA40N, AMO
• Number of people (eyes) randomised: 134 (268)
• Number of people (eyes) excluded after randomisation: 7 (14)
• Number of people (eyes) lost to follow-up: 3 (6)
• Number of people (eyes) analysed (at longest time point): 124 (248)
• Mean age in years: 74
• % female: 51
• Ethnic group: NR
Monofocal: PhacoFlex II SI40NB, AMO
• Number of people (eyes) randomised: 127 (254)
• Number of people (eyes) excluded after randomisation: 9 (18)
• Number of people (eyes) lost to follow-up: 7 (14)
• Number of people (eyes) analysed (at longest time point): 111 (222)
• Mean age in years: 75
• % female: 61
• Ethnic group: NR
Inclusion criteria: aged 50 to 85 years with bilateral cataracts; < 1.5 D of keratometric
cylinder; 20/30 of better potential VA
Exclusion criteria: any pre-existing ocular pathology other than cataract
Pretreatment: no important differences at baseline between both groups
Interventions Intervention characteristics
Multifocal
• Name of lens: Array SA40N, AMO
• Type of lens: zonal-progressive
• Target: +3.5 D for near
Monofocal
• Name of lens: PhacoFlex II SI40NB, AMO
• Type of lens: monofocal
• Target: NR
Both eyes operated
Outcomes Outcomes: distance and near VA, refraction, spectacle independence, satisfaction, visual
function (modified Cataract TyPE questionnaire) and adverse effects (halos, glare, etc.)
Eyes: both eyes operated, binocular outcomes reported
Maximum follow-up: 3 to 6 months after second eye surgery
Notes Sponsorship source: Allergan, Inc
Declaration of interest: “Dr. Javitt and Dr. Steinert are consultants to Allergan, Inc.,
but do not have a proprietary interest in the company or its products.”
Country: USA
Setting: eye hospital
Date study conducted: February 1996 to March 1998
Trial registration ID number: NR
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Javitt 2000 (Continued)
Author’s name: Jonathan C Javitt
Institution:Wilmer Ophthalmological Institute, Johns Hopkins University, Baltimore,
MD
Email: jjavitt@healthdirections.net
Address: 3 Bethesda Metro Center, Suite 100, Bethesda, MD 20814
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Low risk Quote: “A block randomization schedule
by patient was prepared for each site using
SAS software, (SAS Institute, Cary, NC).”
Allocation concealment Unclear risk Quote: “Assigned in blocks of two. For each
block of two patients, either the rst patient
or the second (in random order) received a
multifocal lens. The randomization sched-
ule.”
Quote: “The randomization schedule was
drawn up by site before the start of the
study, and the assignment of each patient
was placed in a sealed container that was
not opened until the patient was actually in
the operating room. Differences between
the ultimate size of the monofocal and
multifocal groups resulted from patients
withdrawing from study after just one im-
plant, sites stopping ahead of schedule, and
chance outcomes.”
Judgement comment: although efforts
make to conceal the allocation a block size
of 2 may have been very easy to second
guess
Blinding of participants and personnel
All outcomes
Low risk Quote: “The patients, the ophthalmic tech-
nicians who collected clinical data, and the
interviewers who collected the quality-of-
life data were all masked as to the type of
lens that each patient received.”
Blinding of outcome assessors
All outcomes
Low risk Quote: “The patients, the ophthalmic tech-
nicians who collected clinical data, and the
interviewers who collected the quality-of-
life data were all masked as to the type of
lens that each patient received.”
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Javitt 2000 (Continued)
Incomplete outcome data
All outcomes
Unclear risk Judgement comment: slightly lower follow-
up inmonofocal group (85%) compared to
92% in multifocal group. A higher propor-
tion of monofocal group participants did
not undergo second eye surgery because of
problems in the first eye 8/127 (6%) com-
pared to 2/134 (1%)
Selective outcome reporting Unclear risk Judgement comment: no access to trial pro-
tocol and trial not registered
Ji 2013
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal: AcrySof ReSTOR, Alcon Laboratories
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 24 (30)
• Mean age in years (range): 63 (52 to 71)
• % female: 58
• Ethnic group: NR
Monofocal: AcrySof Natural, Alcon Laboratories
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 27 (34)
• Mean age in years (range): 63 (55 to 75)
• % female: 56
• Ethnic group: NR
Inclusion criteria: aged 50 to 75 years; age-associated cataracts.
Exclusion criteria: corneal astigmatism > 1.5 D; glaucoma; retinal abnormalities; sur-
gical complications
Pretreatment: NR
Interventions Intervention characteristics
Multifocal
• Name of lens: AcrySof ReSTOR, Alcon Laboratories
• Type of lens: NR
• Target: NR
Monofocal
• Name of lens: AcrySof Natural, Alcon Laboratories
• Type of lens: NA
• Target: NR
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Ji 2013 (Continued)
1 or both eyes operated
Outcomes Outcomes: distance and near VA, contrast sensitivity, refraction, accommodation, aber-
rometry
Eyes: probably reported by eye without adjustment for within-person correlation
Maximum follow-up: 90 days after surgery
Notes Sponsorship source: Shanghai Leading Academic Discipline Project (S30205)
Declaration of interest: NR
Country: China
Setting: eye hospital
Date study conducted: January 2009 to December 2011
Trial registration ID number: NR
Author’s name: Min Luo
Institution: Shanghai Ninth Hospital
Email: qiangson@sh163.net
Address:Department of Ophthalmology, Shanghai Ninth Hospital, Shanghai JiaoTong
University School of Medicine, No. 639 ZhiZaoJu Road, Shanghai 200011, P.R. China
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Unclear risk Judgement comment: sequence generation
NR.
Allocation concealment Unclear risk Judgement comment: allocation conceal-
ment NR.
Blinding of participants and personnel
All outcomes
High risk Judgement comment: masking NR so as-
sume not done.
Blinding of outcome assessors
All outcomes
High risk Judgement comment: masking NR so as-
sume not done.
Incomplete outcome data
All outcomes
Unclear risk Judgement comment: follow-up NR.
Selective outcome reporting Unclear risk Judgement comment: no access to study
protocol or trials registry entry
Jusufovic 2011
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
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Jusufovic 2011 (Continued)
Participants Baseline characteristics
Multifocal: ReZoom NXG1, AMO
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 50 (50)
• Mean age in years (range): 43 (20 to 57)
• % female: 46
• Ethnic group: NR
Monofocal: AcrySof MA60BM, Alcon Laboratories
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 50 (50)
• Mean age in years (range): 50 (26 to 64)
• % female: 42
• Ethnic group: NR
Inclusion criteria: aged 14 to 80 years; astigmatism < 1 D
Exclusion criteria: chronic inflammatory and degenerative diseases of the posterior eye
segment; previous surgery on the eye; high refractive anomalies and systemic diseases,
which can cause changes in the eye, which significantly influence on the vision quality
outcome after the operation
Pretreatment: small difference in age
Interventions Intervention characteristics
Multifocal
• Name of lens: ReZoom NXG1, AMO
• Type of lens: refractive
• Target: NR
Monofocal
• Name of lens: AcrySof MA60BM, Alcon Laboratories
• Type of lens: NA
• Target: NR
1 eye operated
Outcomes Outcomes: distance and near VA, stereo vision
Eyes: binocular
Maximum follow-up: 6 weeks after surgery
Notes Sponsorship source: NR
Declaration of interests: “The authors declare no competing interests.”
Country: Bosnia and Herzegovina
Setting: eye hospital
Date study conducted: February 2006 to January 2007
Trial registration ID number: NR
Author’s name: Jasmin Zvorni anin
Institution: Eye Clinic University Clinical Center Tuzla Tuzla, Bosnia and Herzegovina
Email: zvornicanin jasmin@hotmail.com
Address: Eye Clinic University Clinical Center Tuzla Trnivac bb, 7500 Tuzla, Bosnia
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Jusufovic 2011 (Continued)
and Herzegovina
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Low risk Quote: “Included 50 patients with im-
planted monofocal IOLs. Randomization
was performed as follows: 100 small folded
pieces of paper on which ”multi“ or
”mono“ was written, are folded and placed
in an opaque bag.”
Allocation concealment Low risk Quote: “The nurse who did not participate
in the study picked papers from the bag
and divided patients into two groups. Also,
surgeon who carried out the operations did
not know which group does the patient be-
long, until the very moment of intraocular
lens implantation.”
Blinding of participants and personnel
All outcomes
High risk Judgement comment: masking NR.
Blinding of outcome assessors
All outcomes
High risk Judgement comment: masking NR.
Incomplete outcome data
All outcomes
Unclear risk Judgement comment: follow-up NR.
Selective outcome reporting Unclear risk Judgement comment: no access to study
protocol or trials registry entry
Kamlesh 2001
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal: Progress 3, Laboratoires Domilens
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 20 (NR)
• Mean age in years: 56
• % female: NR
• Ethnic group: NR
Monofocal: Flex 65, Laboratoires Domilens
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• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 20 (NR)
• Mean age in years: 54
• % female: NR
• Ethnic group: NR
Inclusion criteria: age-related cataract
Exclusion criteria: known disease likely to interfere with postoperative visual outcome;
preoperative astigmatism > 1.50 D; axial length beyond that requiring an estimated IOL
power of 18.00 D to 24.00 D for emmetropia; previous eye surgery
Pretreatment: quite large differences in near vision with 90% of multifocal group hav-
ing distance-corrected near vision ≥ N9 compared to 10% of the monofocal group.
Monofocal group had worse distance VA as well
Interventions Intervention characteristics
Multifocal
• Name of lens: Progress 3, Laboratoires Domilens
• Type of lens: NR
• Target: + 3.00 D
Monofocal
• Name of lens: Flex 65, Laboratoires Domilens
• Type of lens: NA
• Target: emmetropia
1 eye operated
Outcomes Outcomes: contrast sensitivity, depth of focus, satisfaction, spectacle use and adverse
effects (glare, halo, etc.)
Eyes: unclearly reported, probably by eye as unilateral surgery
Maximum follow-up: 3 months after surgery
Notes Sponsorship source: NR
Declaration of interest: “The authors do not have any financial interest in any of the
products mentioned in this article.”
Country: India
Setting: eye hospital
Date study conducted: NR
Trial registration ID number: NR
Author’s name: Dr Subhash Dadeya
Institution: Guru Nanak Eye Centre, Maulana Asad Medical College
Email: sdadeya@freedialin.com
Address: 197 Rouse Ave, New Delhi 110002, India
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Unclear risk Judgement comment: sequence generation
NR.
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Allocation concealment High risk Judgement comment: allocation conceal-
ment NR and considerable baseline imbal-
ance in groups with respect to near vision
Blinding of participants and personnel
All outcomes
High risk Judgement comment: masking NR.
Blinding of outcome assessors
All outcomes
High risk Judgement comment: masking NR.
Incomplete outcome data
All outcomes
Unclear risk Judgement comment: follow-up NR.
Selective outcome reporting Unclear risk Judgement comment: no access to trial pro-
tocol or registry entry
Labiris 2015
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal: Isert PY60MV, Hoya Surgical Optics
• Number of people (eyes) randomised: 37 (74)
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): NR
• Mean age in years (range): 61 (NR)
• % female: NR
• Ethnic group: NR
Monofocal: SN60WF, Alcon Laboratories
• Number of people (eyes) randomised: 38 (76)
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): NR
• Mean age in years (range): 60 (NR)
• % female: NR
• Ethnic group: NR
Inclusion criteria: age-related cataract with grade 2 nuclear opalescence according to
the Lens Opacities Classification System III grading scale
Exclusion criteria: manifest astigmatism > 1.00 D; reports of headaches or eyestrain
(or both) associated with visual activities; positive pathological ocular cover test (near
and distance) or the Mallett disparity test (near and distance) (or both) and the dou-
ble Maddox rod test; endothelial cell count < 1900 cells/mm2; glaucoma; intraocular
pressure-lowering medications; former incisional surgery; former diagnosis of corneal
disease; former diagnosis of fundus disease; diabetes; autoimmune or mental diseases
Pretreatment: no major imbalances in age and grade of cataract
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Interventions Intervention characteristics
Multifocal
• Name of lens: Isert PY60MV, Hoya Surgical Optics
• Type of lens: refractive
• Target: +3.00 D of near addition
Monofocal
• Name of lens: SN60WF, Alcon Laboratories
• Type of lens: NA
• Target: targeting -0.50 D in the dominant eye and -1.25 D in the non-dominant
eye.
Both eyes operated
Outcomes Outcomes: dysphotopsia, need for spectacles, Visual Function Index-14, binocular un-
corrected distance and near VA, contrast sensitivity and stereo acuity
Eyes: both eyes operated, measurements binocular
Maximum follow-up: 6 months after surgery
Notes Sponsorship source: NR
Declaration of interest: “No author has a financial or proprietary interest in anymaterial
or method mentioned.”
Country: Greece
Setting: eye hospital
Date study conducted: January 2013 to July 2013
Trial registration ID number: NR
Author’s name: Georgios Labiris
Institution: Ophthalmology Department, University Hospital of Alexandroupolis
Email: labiris@usa.net
Address: Ophthalmology Department, University Hospital of Alexandroupolis, 68100
Dragana, Alexandroupolis, Greece
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Low risk Quote: “Using a custom computer ran-
domization program, all patients randomly
populated 2 study groups according to the
cataract extraction technique used: mono-
vision and multifocal IOL.”
Allocation concealment Unclear risk Judgement comment: not described.
Blinding of participants and personnel
All outcomes
High risk Judgement comment: masking not de-
scribed. On clinical trials registry entry de-
scribed as “open label”
Blinding of outcome assessors
All outcomes
Unclear risk Quote: “All preoperative and postoperative
assessments were done by the same oph-
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thalmologist, who had no direct involve-
ment in the study.”
Judgement comment: unclear if this person
was masked or not.
Incomplete outcome data
All outcomes
Unclear risk Judgement comment: NR.
Selective outcome reporting Low risk Judgement comment: all outcomes on clin-
ical trials registry entry reported
Leyland 2002
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal 1: Array SA40NB, Allergan
• Number of people (eyes) randomised: 31 (62)
• Number of people (eyes) excluded after randomisation: 2 (4)
• Number of people (eyes) lost to follow-up: 0 (0)
• Number of people (eyes) analysed (at longest time point): 29 (58)
• Mean age in years: 75
• % female: 53
• Ethnic group: NR
Multifocal 2: TrueVista 68STUV, Storz
• Number of people (eyes) randomised: 19 (38)
• Number of people (eyes) excluded after randomisation: 4 (8)
• Number of people (eyes) lost to follow-up: 0 (0)
• Number of people (eyes) analysed (at longest time point): 15 (30)
• Mean age in years: 74
• % female: 60
• Ethnic group: NR
Monofocal: PhacoFlex I SI40N, AMO
• Number of people (eyes) randomised: 19 (38)
• Number of people (eyes) excluded after randomisation: 3 (6)
• Number of people (eyes) lost to follow-up: 0 (0)
• Number of people (eyes) analysed (at longest time point): 16 (32)
• Mean age in years: 76
• % female: 44
• Ethnic group: NR
Inclusion criteria: aged > 18 years; bilateral visually significant cataracts with extraction
indicated; informed consent; ability to understand and complete TyPE questionnaire
Exclusion criteria: macular or other pathology considered likely to limit postoperative
acuity to worse than 6/9 in either eye; corneal astigmatism > 1.5 D in either eye; required
IOL power outside range available for multifocal IOL (16 D to 24 D)
Pretreatment: there were no significant intergroup differences in age, sex, preoperative
BCVA and visual satisfaction
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Interventions Intervention characteristics
Multifocal 1
• Name of lens: Array SA40NB, Allergan
• Type of lens: refractive
• Target: emmetropia
Multifocal 2
• Name of lens: TrueVista 68STUV, Storz
• Type of lens: bifocal
• Target: emmetropia
Monofocal
• Name of lens: PhacoFlex SI40N, Allergan
• Type of lens: NA
• Target: emmetropia
Both eyes operated
Outcomes Outcomes: distance and near VA, refraction, contrast sensitivity, depth of focus, satis-
faction and visual function (TyPE questionnaire including bother from glare/halos) and
spectacle use
Eyes: binocular for acuity outcomes, monocular not adjusted with within-person corre-
lation for refractive outcomes
Maximum follow-up: 12 months after surgery
Notes Sponsorship source: NR
Declaration of interest: “The authors have no financial interest in any of the products
described in this paper.”
Country: UK
Setting: eye hospital
Date study conducted: NR
Trial registration ID number: NR
Author’s name: Martin D Leyland
Institution: Royal Berkshire Hospital
Email: Martin.Leyland@rbbh-tr.nhs.uk
Address: London Road, Reading Berks RG1 5AN, UK
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Unclear risk Judgement comment: NR.
Allocation concealment Low risk Judgement comment: sealed envelopes
opened on the day of surgery
Blinding of participants and personnel
All outcomes
Unclear risk Judgement comment: participants were in-
formed that the IOL type implanted would
not be revealed to them until completion
of the trial but a proportion of participants
were reported to be unmasked
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Blinding of outcome assessors
All outcomes
Low risk Judgement comment: the hospital op-
tometrist and the ophthalmic nurse special-
ist carrying out these tests were masked as
to the nature of the IOL implanted
Incomplete outcome data
All outcomes
Unclear risk Judgement comment: follow-up < 80% at
1 year.
Selective outcome reporting Unclear risk Judgement comment: no access to protocol
or trials registry entry
Nijkamp 2004
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal: Array SA40N, AMO
• Number of people (eyes) randomised: 93
• Number of people (eyes) excluded after randomisation: 11
• Number of people (eyes) lost to follow-up: 14
• Number of people (eyes) analysed (at longest time point): 68
• Mean age in years: 72
• % female: 67
• Ethnic group: NR
Monofocal: PhacoFlex II SI40NB, AMO
• Number of people (eyes) randomised: 97
• Number of people (eyes) excluded after randomisation: 19
• Number of people (eyes) lost to follow-up: 9
• Number of people (eyes) analysed (at longest time point): 69
• Mean age in years: 72
• % female: 64
• Ethnic group: NR
Inclusion criteria: bilateral senile cataract; astigmatism < 1.5 D; spectacle sphere -6.0
to +4.0 D; axial length 19.5 mm to 26 mm; ability to complete questionnaires in Dutch
Exclusion criteria: professional night driver; mental retardation (diagnosed in the med-
ical file or concluded by contact by telephone); any eye disease other than cataract that
might limit postoperative vision
Pretreatment: slightly more astigmatism in the monofocal group
Interventions Intervention characteristics
Multifocal
• Name of lens: Array SA40N, AMO
• Type of lens: NR
• Target: emmetropia
Monofocal
• Name of lens: PhacoFlex II SI40NB, AMO
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• Type of lens: NA
• Target: emmetropia
Both eyes operated
Outcomes Participants with a postoperative refractive error in SE of > 1.5 D from emmetropia (in
at least 1 eye) were excluded from further analyses (monofocal, n = 8; multifocal, n = 3)
Outcomes: distance and near VA, refraction, contrast sensitivity, depth of focus, satis-
faction, visual function and quality of life (including VF-14 and Visual Quality of Life)
, Cataract Symptom Score, spectacle dependence
Eyes: largely unclear how dealt with eyes, measurements monocular
Maximum follow-up: 3 months after surgery
Notes Sponsorship source: Eye Research Institute Maastricht (Maastricht, The Netherlands)
Declaration of interest: “None of the authors has a financial or proprietary interest in
any product or device mentioned.”
Country: the Netherlands
Setting: eye hospital
Date study conducted: August 1999 to January 2001
Trial registration ID number: NR
Author’s name: Marjan D Nijkamp
Institution: Maastricht University
Email: M.Nijkamp@GVO.unimaas.nl
Address: Department of Health Education and Health Promotion, Maastricht Univer-
sity, PO Box 616, 6200 MD Maastricht, the Netherlands
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Low risk Quote: “Block randomization by means of
a computerized random number generator
was used to keep the number of subjects in
the different groups balanced.”
Allocation concealment Low risk Quote: “After the preoperative assessments,
a technical ophthalmic assistant allocated
the treatment condition via a sealed enve-
lope that contained a card identifying the
lens type. The envelope was opened by a
nurse not involved in the study. This was
done after biometry and just before surgery,
to enable the ophthalmologist to choose the
correct lens power.”
Blinding of participants and personnel
All outcomes
High risk Quote: “Patients were masked with respect
to the type of lens until the first postopera-
tive visit. It was unfeasible to keep patients
masked postoperatively, because they were
aware of the characteristics of both types of
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IOL from their description in the patient
information they received.”
Quote: “Interviewers and ophthalmolo-
gists were unaware of the treatment group
of the patient at the preoperative tests.
However, because there were perceptible
differences between the 2 types of lenses
during the slit-lamp examination, masking
of interviewers and ophthalmologists was
not feasible postoperatively.”
Blinding of outcome assessors
All outcomes
High risk Quote: “Interviewers and ophthalmolo-
gists were unaware of the treatment group
of the patient at the preoperative tests.
However, because there were perceptible
differences between the 2 types of lenses
during the slit-lamp examination, masking
of interviewers and ophthalmologists was
not feasible postoperatively.”
Incomplete outcome data
All outcomes
High risk Judgement comment: rather high loss to
follow-up (approximately 30%)potentially
linked to outcome although similar loss to
follow-up in both groups. Excluded people
with high astigmatism after surgery
Quote: “Patients with a postoperative re-
fractive error in spherical equivalent (SE)
of >1.5 D from emmetropia (in at least one
eye) were excluded from further analyses
(Fig 1; monofocal, n=8; multifocal, n=3).”
Selective outcome reporting Unclear risk Judgement comment: no access to protocol
or trials registry entry
Palmer 2008
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal 1: Tecnis ZM900, AMO
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 26 (52)
• Mean age in years: 73
• % female: 61
• Ethnic group: NR
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Multifocal 2: ReZoom, AMO
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 32 (64)
• Mean age in years: 72
• % female: 69
• Ethnic group: NR
Multifocal 3: TwinSet, Acri.Tec GmbH
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 32 (64)
• Mean age in years: 74
• % female: 67
• Ethnic group: NR
Monofocal: Tecnis Z9000, AMO
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 24 (48)
• Mean age in years: 75
• % female: 53
• Ethnic group: NR
Inclusion criteria: both eyes healthy with no disease except cataract
Exclusion criteria: professional drivers
Pretreatment: some differences in gender and SE between groups
Interventions Intervention characteristics
Multifocal 1
• Name of lens: Tecnis ZM900, AMO
• Type of lens: diffractive
• Target: NR
Multifocal 2
• Name of lens: ReZoom, AMO
• Type of lens: refractive
• Target: NR
Multifocal 3
• Name of lens: TwinSet, Acri.Tec GmbH
• Type of lens: diffractive
• Target: NR
Monofocal
• Name of lens: Tecnis Z9000, AMO
• Target: NR
Both eyes operated
Outcomes Outcomes: distance and near VA, refraction, contrast sensitivity, visual symptoms, spec-
tacle dependence for near tasks
Eyes: binocular and monocular, no adjustment for within-person correlation
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Maximum follow-up: 3 months after surgery
Notes Sponsorship source: NR
Declaration of interest: “The authors have no financial interest in the materials pre-
sented herein.”
Country: Spain
Setting: eye hospital
Date study conducted: June 2004 to March 2005
Trial registration ID number: NR
Author’s name: Ana Martinez Palmer
Institution: University of Barcelona
Email: 28653amp@comb.es
Address: Department of Ophthalmology, Hospital Universitario del Mar and Hospital
de la Esperanza, Memorial Cristobal Garrigosa, Autonomous University of Barcelona,
Barcelona, Spain
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Unclear risk Judgement comment: NR.
Allocation concealment High risk Judgement comment: “Sealed envelope
method” but not enough detail to be clear
what they did and some differences be-
tween groups in terms of gender and pre-
operative SE
Blinding of participants and personnel
All outcomes
Unclear risk Judgement comment: participants were
not told which lens they would receive but
unclear whether any of them could have
guessed. This was not discussed
Blinding of outcome assessors
All outcomes
Unclear risk Quote: “Refraction measurements were
performed by a single independent ob-
server who was unaware of the purpose of
the study.”
Judgement comment: this judgement ap-
plies to refraction outcomes only
Incomplete outcome data
All outcomes
Unclear risk Judgement comment: NR.
Selective outcome reporting Unclear risk Judgement comment: no access to trial reg-
istry entry or study protocol
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Peng 2012
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal: AcrySof ReSTOR SN6AD1, Alcon Laboratories
• Number of people (eyes) randomised: 51 (102)
• Number of people (eyes) excluded after randomisation: 1 (2)
• Number of people (eyes) lost to follow-up: 0 (0)
• Number of people (eyes) analysed (at longest time point): 50 (100)
• Mean age in years: 66
• % female: 58
• Ethnic group: not stated (presume Chinese?)
Monofocal: AcrySof IQ SN60WF, Alcon Laboratories
• Number of people (eyes) randomised: 51 (102)
• Number of people (eyes) excluded after randomisation: 0 (0)
• Number of people (eyes) lost to follow-up: 0 (0)
• Number of people (eyes) analysed (at longest time point): 51 (102)
• Mean age in years: 67
• % female: 47
• Ethnic group: not stated (presume Chinese?)
Inclusion criteria: bilateral cataract; aged 50 to 75 years; axial length 22.0 mm to 24.
0 mm; preoperative corneal astigmatism < 2.0 D; nuclear hardness from grade II to IV
based on the Emery-Little classification; corneal endothelium cell count > 2000 cells/
mm2
Exclusion criteria: myopia or hyperopia > 3.00 D; history of amblyopia; fundus ab-
normalities; previous corneal or intraocular surgery; ocular comorbidity (e.g. previous
trauma, glaucoma, abnormal iris, chronic uveitis, macular degeneration or retinopathy,
neuro-ophthalmic disease). Intraoperative exclusion criteria: iris pupil trauma; vitreous
loss; IOL tilt
Pretreatment: some differences between study groups in pupil size and intraocular stray-
light
Interventions Intervention characteristics
Multifocal
• Name of lens: AcrySof ReSTOR SN6AD1, Alcon Laboratories
• Type of lens: diffractive
• Target: emmetropia
Monofocal
• Name of lens: AcrySof IQ SN60WF, Alcon Laboratories
• Type of lens: NA
• Target: emmetropia
Both eyes operated
Outcomes Outcomes: distance, near and intermediate VA, refraction, contrast sensitivity, defocus
curves, aberrations, visual problems, satisfaction, spectacle independence, adverse effects
(including PCO, glare, etc.)
Eyes: binocular acuity, other measures largely unclear, no adjustment for within-person
correlation
Maximum follow-up: 6 months after surgery
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Notes Sponsorship source: Education Department of Liaoning Province grants, China
(2009R53); andScience andTechnologyDepartment of LiaoningProvince grants, China
(2009225011-3)
Declaration of interest: “No author has a proprietary or commercial interest in the
materials or methods mentioned here.”
Country: China
Setting: eye hospital
Date study conducted: NR
Trial registration ID number: NR
Author’s name: Jinsong Zhang
Institution: Fourth Affiliated Hospital of China Medical University
Email: cmu.jszhang@gmail.com
Address:Department of Ophthalmology the Fourth Affiliated Hospital of China Med-
ical University, 11 Xinhua Road, Shenyang, 110005, China
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Unclear risk Judgement comment: method of randomi-
sation not described. Opaque envelopes
were selected
Allocation concealment Low risk Quote: “Patients were randomised to each
of the IOLs by selecting an unmarked,
opaque envelope for each patient from a
total of 102 envelopes evolving the type of
one of the IOLs. The envelope was opened
by a staff not involved in our study.”
Blinding of participants and personnel
All outcomes
Unclear risk Quote: “This prospective, randomised,
comparative, and observer-masked trial re-
cruited 204 eyes (102 patients).”
Judgement comment: it was not clear how
the masking was done
Blinding of outcome assessors
All outcomes
Unclear risk Quote: “This prospective, randomised,
comparative, and observer-masked trial.”
Judgement comment: it was not clear how
the masking was done
Incomplete outcome data
All outcomes
Low risk Quote: “A total of 101 patients were avail-
able at 6 month postoperatively, owing to
the presence of posterior capsular opacities
in the multifocal IOL group. Therefore, 50
patients (100 eyes) in the multifocal IOL
group and 51 patients (102 eyes) in the
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monofocal IOL group were available for
analysis.”
Judgement comment: 100/101 partici-
pants followed to 6 months
Selective outcome reporting Unclear risk Judgement comment: no protocol or trials
registry entry.
Percival 1993
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal: MPC25, AMO
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 25 (25)
• Mean age in years (range): 77 (59 to 89)
• % female: 58
• Ethnic group: NR
Monofocal: PC25, AMO
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 25 (25)
• Mean age in years (range): 78 (60 to 92)
• % female: 58
• Ethnic group: NR
Inclusion criteria: not specified
Exclusion criteria: any other ocular pathology
Pretreatment: 5 participants dropped out of study (due to death, undiagnosed diabetic
retinopathy and undiagnosed macular degeneration) and replaced by other randomised
participants - unclear which groups these participants were lost from
Interventions Intervention characteristics
Multifocal
• Name of lens: MPC25, AMO
• Type of lens: refractive
• Target: SE -0.50 to +0.50 D with cylinder < 1.00 D
Monofocal
• Name of lens: PC25, AMO
• Type of lens: NA
• Target: SE -0.30 to -1.30 D with cylinder of 1.00 to 1.75 D
1 eye operated
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Outcomes Outcomes: distance and near VA, refraction, contrast sensitivity, satisfaction, operative
and postoperative complications, and adverse effects (including glare, etc.)
Eyes: 1 eye operated per person
Maximum follow-up: 4 to 6 months after surgery
Notes Sponsorship source: NR
Declaration of interest: NR
Country: UK
Setting: eye hospital
Date study conducted: NR
Trial registration ID number: NR
Author’s name: SPB Percival
Institution: Scarborough Hospital
Email: NR
Address: Department of Ophthalmology, Scarborough Hospital, Scarborough, North
Yorkshire, YO12 6QL, UK
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Unclear risk Judgement comment: NR.
Allocation concealment Unclear risk Judgement comment: NR.
Blinding of participants and personnel
All outcomes
High risk Judgement comment: no suggestion of
masking in the trial description
Blinding of outcome assessors
All outcomes
High risk Judgement comment: no description of
masking.
Incomplete outcome data
All outcomes
High risk Judgement comment: follow-up not clearly
reported: 5/30 dropped out and not clear
which group they were allocated to
Selective outcome reporting Unclear risk Judgement comment: no access to study
protocol or trials registry entry
Rasp 2012
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal 1: AcrySof ReSTOR SN6AD3, Alcon Laboratories
• Number of people (eyes) randomised: NR
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• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 28 (56)
• Mean age in years (range): 76 (62 to 91)
• % female: NR
• Ethnic group: NR
Multifocal 2: AT LISA 366D, Carl Zeiss
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 30 (60)
• Mean age in years (range): 74 (63 to 89)
• % female: NR
• Ethnic group: NR
Multifocal 3: ReZoom, AMO
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 30 (60)
• Mean age in years (range): 79 (66 to 89)
• % female: NR
• Ethnic group: NR
Multifocal 4: Tecnis ZMA00, AMO
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 29 (58)
• Mean age in years (range): 75 (62 to 87)
• % female: NR
• Ethnic group: NR
Monofocal: Acri.Smart 48S (also known as CT Spheris 209M), Carl Zeiss
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 29 (58)
• Mean age in years (range): 76 (63 to 80)
• % female: NR
• Ethnic group: NR
Inclusion criteria: aged > 60 year; and participants seeking bilateral cataract refractive
surgery for presbyopia in the presence of significant nuclear sclerosis
Exclusion criteria: additional ocular disease and illiteracy
Pretreatment: there were statistically significant between-group differences in sphere,
cylinder, corrected distance VA, axial length, anterior chamber depth and IOL power.
These differences were the result of the randomisation process and do not represent
selection bias
Interventions Intervention characteristics
Multifocal 1
• Name of lens: AcrySof ReSTOR SN6AD3, Alcon Laboratories
• Type of lens: refractive/diffractive
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Rasp 2012 (Continued)
• Target: NR
Multifocal 2
• Name of lens: AT LISA 366D, Carl Zeiss
• Type of lens: refractive-diffractive bifocal
• Target: NR
Multifocal 3
• Name of lens: ReZoom, AMO
• Type of lens: refractive
• Target: NR
Multifocal 4
• Name of lens: Tecnis ZMA00, AMO
• Type of lens: diffractive
• Target: NR
Monofocal
• Name of lens: Acri.Smart 48S (also known as CT Spheris 209M), Carl Zeiss
• Type of lens: NA
• Target: NR
Both eyes operated
Outcomes Outcomes: distance VA, refraction, reading ability
Eyes: monocular, no adjustment for within-person correlation
Maximum follow-up: 12 months after surgery
Notes Sponsorship source: NR
Declaration of interest: “Drs. Grabner and Dexl were patent owners of the Salzburg
Reading Desktechnology (now owned by SRD-Vision, LLC). No other author has a
financial or proprietary interest in any material or method mentioned.”
Country: Austria
Setting: eye hospital
Date study conducted: NR
Trial registration ID number: NR
Author’s name: Alois K Dexl
Institution: Paracelsus Medical University
Email: a.dexl@salk.at
Address: Paracelsus Medical University, Department of Ophthalmology, Salzburg, Aus-
tria
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Unclear risk Judgement comment: NR.
Allocation concealment Unclear risk Judgement comment: NR.
Blinding of participants and personnel
All outcomes
High risk Judgement comment: NR.
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Rasp 2012 (Continued)
Blinding of outcome assessors
All outcomes
Unclear risk Judgement comment: NR.
Incomplete outcome data
All outcomes
Unclear risk Judgement comment: NR.
Selective outcome reporting Unclear risk Judgement comment: no access to study
protocol or trials registry entry
Rossetti 1994
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal: 3M Vision Care multifocal IOL
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 38 (38)
• Mean age in years (range): 72 (55 to 84)
• % female: 61
• Ethnic group: NR
Monofocal, NR
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 42 (42)
• Mean age in years (range): 70 (50 to 90)
• % female: 57
• Ethnic group: NR
Inclusion criteria: astigmatism ≤ 2.5 D; SE in the fellow eye of no more than 2.5 D;
cataract in 1 eye and clear lens or early cataract in the fellow eye that would not require
surgery during the study
Exclusion criteria: astigmatism >1.5D; IOL in fellow eye; fundus abnormalities causing
significant vision impairment; could not be followed for 1 year
Pretreatment: no group differences
Interventions Intervention characteristics
Multifocal
• Name of lens: 3M Vision Care multifocal IOL
• Type of lens: refractive and diffractive
• Target: emmetropia
Monofocal
• Name of lens: NR
• Type of lens: NA
• Target: emmetropia
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Rossetti 1994 (Continued)
1 eye operated
Outcomes Outcomes: distance and near VA, contrast sensitivity, satisfaction, spectacle dependence,
adverse effects (including glare, halos, etc.)
Eyes: 1 eye operated per participant
Maximum follow-up: 12 months after surgery
Notes Sponsorship source: NR
Declaration of interest: NR
Country: Italy
Setting: eye hospital
Date study conducted: NR
Trial registration ID number: NR
Author’s name: Luca Rossetti
Institution: University of Milan
Email: NR
Address: Department of Ophthalmology, University of Milan, Institute of Biomedical
Sciences, S. Paulo Hospital, Milan, Italy
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Unclear risk Judgement comment: NR.
Allocation concealment Unclear risk Judgement comment: NR.
Blinding of participants and personnel
All outcomes
High risk Judgement comment: no information on
masking.
Blinding of outcome assessors
All outcomes
High risk Judgement comment: no information on
masking.
Incomplete outcome data
All outcomes
Unclear risk Judgement comment: NR.
Selective outcome reporting Unclear risk Judgement comment: no access to trials
registry entry or study protocol
Sen 2004
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: no
Participants Baseline characteristics
Multifocal: Array SA40N, AMO
• Number of people (eyes) randomised: 40 (NR)
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Sen 2004 (Continued)
• Number of people (eyes) excluded after randomisation: 5 (NR)
• Number of people (eyes) lost to follow-up: 0 (0)
• Number of people (eyes) analysed (at longest time point): 35 (53)
• Mean age in years (range): 69 (48 to 84)
• % female: 74
• Ethnic group: NR
Monofocal: PhacoFlex II SI40NB, AMO
• Number of people (eyes) randomised: 40 (NR)
• Number of people (eyes) excluded after randomisation: 0 (0)
• Number of people (eyes) lost to follow-up: 0 (0)
• Number of people (eyes) analysed (at longest time point): 40 (67)
• Mean age in years (range): 72 (41 to 88)
• % female: 63
• Ethnic group: NR
Inclusion criteria: both eyes had to be healthy, with no disease except cataract; required
to understand the possible benefit of having implantation of a multifocal IOL instead
of a monofocal IOL; have potential good vision in both eyes after cataract surgery and
IOL implantation
Exclusion criteria: participants who would likely be more sensitive to glare, halos, and
changes in contrast sensitivity; and who did not have realistic expectations of the new
technology
Pretreatment: there were no significant between-group differences in demographics
including age, sex, education and profession. VA and the type of cataract were comparable
between groups, and no participant in either group had ocular comorbidity in addition to
cataract. The VF-7 and CS-5 values were almost identical in the 2 groups preoperatively,
and the percentages of those reporting being dissatisfied with their vision (43.1% in
multifocal group and 57.6% in monofocal group) or very dissatisfied with their vision
(19.6% in multifocal group and 18.2% in monofocal group) were comparable. The
proportion of participants with moderate (35.3% in multifocal group and 25.8% in
monofocal group) or a great deal (25.5% in multifocal group and 21.2% in monofocal
group) of self-reported trouble with vision was also comparable between the 2 groups
Interventions Intervention characteristics
Multifocal
• Name of lens: Array SA40N, AMO
• Type of lens: refractive
• Target: NR
Monofocal
• Name of lens: PhacoFlex II SI40NB, AMO
• Type of lens: NA
• Target: NR
1 or both eyes operated
Outcomes Outcomes: distance and near VA, refraction, contrast sensitivity, range of accommoda-
tion, visual function (VF-7), visual symptoms, satisfaction, adverse effects (glare, halos,
etc.)
Eyes: monocular acuity, no adjustment for within-person correlation
Maximum follow-up: 1 month after surgery
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Sen 2004 (Continued)
Notes Sponsorship source: supported by a special government grant for research (TYH 3234),
Helsinki University EyeHospital, and a grant from the Finnish Eye Foundation, Helsinki
Finland, and a grant to help in statistical analysis from Allergan Norden
Declaration of interest: “None of the authors has a financial or proprietary interest in
any material or method mentioned.”
Country: Finland
Setting: eye Hospital
Date study conducted: February 1998 to August 2002
Trial registration ID number: NR
Author’s name: Risto J Uusitalo
Institution: Helsinki University Eye Hospital
Email: risto.uusitalo@hus.fi
Address:Helsinki University EyeHospital, PO Box 220, 00029 HUS,Helsinki, Finland
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Unclear risk Judgement comment: NR.
Allocation concealment Unclear risk Judgement comment: sealed-
envelope method was used but no further
details given
Blinding of participants and personnel
All outcomes
High risk Judgement comment: participants and per-
sonnel were not blinded
Blinding of outcome assessors
All outcomes
High risk Judgement comment: no blinding was
done.
Incomplete outcome data
All outcomes
High risk Judgement comment: 5/40 participants in
multifocal group only excluded after ran-
domisation
Selective outcome reporting Unclear risk Judgement comment: no access to study
protocol or trials registry entry
Steinert 1992
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: yes
Participants Baseline characteristics
Multifocal: Array MPC-25NB, AMO
• Number of people (eyes) randomised: 40
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: 8
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Steinert 1992 (Continued)
• Number of people (eyes) analysed (at longest time point): 32 (32)
• Mean age in years: 72
• % female: 55
• Ethnic group: NR
Monofocal: PC-26NB, AMO
• Number of people (eyes) randomised: 40
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: 10
• Number of people (eyes) analysed (at longest time point): 30 (30)
• Mean age in years: 71
• % female: 78
• Ethnic group: NR
Inclusion criteria: functionally disabling cataracts; potential acuity of ≥ 20/25; preop-
erative cylinder of ≤ 1.5 D; axial myopia < 26 mm; phakic fellow eye
Exclusion criteria: non-cataract ocular pathology
Pretreatment: significant gender difference between both study groups (P = 0.033)
Interventions Intervention characteristics
Multifocal
• Name of lens: Array MPC-25NB, AMO
• Type of lens: refractive
• Target: NR
Monofocal
• Name of lens: PC-26NB, AMO
• Type of lens: NA
• Target: NR
1 eye operated
Outcomes Outcomes: distance and near, refraction, contrast sensitivity, visual problems (including
glare, halos, etc.), satisfaction and spectacle use
Eyes: Only 1 eye operated
Maximum follow-up: 3 to 6 months after surgery (mean follow-up approximately 4
months)
Notes Sponsorship source: “Supported in part by AllerganMedical Optics, Irving, California”
Declaration of interest: “None of the authors has any proprietary or financial interest in
the devices used in this study. Dr Steinert is a member of the Allergan Scientific Advisory
Committee, for which a stipend is received.Drs Steinert andOksman are unpaid medical
monitors for the multifocal intraocular lens used in this study.”
Country: USA
Setting: eye hospital
Date study conducted: NR
Trial registration ID number: NR
Author’s name: Roger F Steinert
Institution: Massachusetts Eye and Ear Infirmary and the Harvard Medical School,
Boston, MA
Email: NR
Address: Center for Eye Research, Ophthalmic Consultants of Boston, 50 Staniford St,
Boston, MA 02114, USA
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Steinert 1992 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Unclear risk Judgement comment: randomised block
design but no further details
Allocation concealment Unclear risk Judgement comment: NR.
Blinding of participants and personnel
All outcomes
Low risk Quote: “The lenses were centrally encoded
and labelled such that the patient record
did not indicate which IOLwas implanted.
Both the patient and ophthalmic technical
staff performing objective measures were
masked regarding the identity of the im-
plant.”
Blinding of outcome assessors
All outcomes
Low risk Quote: “The lenses were centrally encoded
and labelled such that the patient record
did not indicate which IOLwas implanted.
Both the patient and ophthalmic technical
staff performing objective measures were
masked regarding the identity of the im-
plant.”
Incomplete outcome data
All outcomes
High risk Judgement comment: only 77% followed
up and not clear if equal between groups
Selective outcome reporting Unclear risk Judgement comment: no access to study
protocol or trials registry entry
Wilkins 2013
Methods Study design: randomised controlled trial
Study grouping: parallel group
Multicentre: yes
Participants Baseline characteristics
Multifocal: Tecnis ZM900, AMO
• Number of people (eyes) randomised: 106 (212)
• Number of people (eyes) excluded after randomisation: 6 (12)
• Number of people (eyes) lost to follow-up: 6 (12)
• Number of people (eyes) analysed (at longest time point): 94 (188)
• Mean age in years (range): 67 (NR)
• % female: 56
• Ethnic group: NR
Monofocal: Akreos AO, Bausch & Lomb
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Wilkins 2013 (Continued)
• Number of people (eyes) randomised: 105 (210)
• Number of people (eyes) excluded after randomisation: 2 (4)
• Number of people (eyes) lost to follow-up: 10 (20)
• Number of people (eyes) analysed (at longest time point): 93 (186)
• Mean age in years (range): 69 (NR)
• % female: 58
• Ethnic group: NR
Inclusion criteria: bilateral cataract surgery; aged 30 to 90 years; axial lengthmeasurable
using the Zeiss IOLMaster (Oberkochen, Germany)
Exclusion criteria: IOL power available to achieve emmetropia with IOL or -1.5 D with
the Akreos AO IOL (Bausch & Lomb, Rochester, NY); significant copathology likely
to reduce acuity or visual field; keratometric astigmatism likely to be ≥ 1.0 D in either
eye after surgery; amblyopia; congenital or traumatic cataracts; poor comprehension of
written or spoken English; inability to give informed consent
Pretreatment: the 2 groups of the study were similar in age (68.7 ± 12.0 years for
monovision vs 67.0 ± 11.2 for multifocal) and sex (female 57.5% for monovision vs
female 55.7% for multifocal)
Interventions Intervention characteristics
Multifocal
• Name of lens: Tecnis ZM900, AMO
• Type of lens: diffractive
• Target: emmetropia
Monofocal
• Name of lens: Akreos AO, Bausch & Lomb
• Type of lens: monovision
• Target: emmetropia in distance eye; myopia -1.0 to -1.5 D in the near eye
Both eyes operated
Outcomes Outcomes: distance, near and intermediate VA, refraction, contrast sensitivity, stray-
light, aberrations, stereo acuity, visual problems (dysphopsia), satisfaction, spectacle de-
pendence, visual function (VF-14)
Eyes: binocular acuity or right eye only
Maximum follow-up: 4 months after surgery
Notes Sponsorship source: “Funded by an unrestricted grant from Abbott Medical Optics
and Bausch &Lomb. The funding organizations had no role in the design or conduct of
this research. This work was supported in part by the UK National Institute for Health
Research Biomedical Research Centre in Ophthalmology at Moorfields Eye Hospital
and UCL Institute of Ophthalmology.”
Declaration of interest: “The author(s) have no proprietary or commercial interest in
any materials discussed in this article.”
Country: UK
Setting: eye hospital
Date study conducted: April 2007 to August 2010
Trial registration ID number: ISRCTN37400841
Author’s name: Mark Wilkins
Institution: Moorfields Eye Hospital
Email: mark.wilkins@moorfields.nhs.uk
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Wilkins 2013 (Continued)
Address:Moorfields Eye Hospital, 162 City Road, London, EC1V 2PD, UK
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Low risk Quote: “Randomizationwas conducted us-
ing minimization that incorporated a sin-
gle factor, hospital site, using Minim, a free
minimization program (available at www-
users.york.ac.uk/wmb55/guide/ minim.
htm, accessed July 22, 2013).”
Allocation concealment Low risk Quote: “Access to the procedure was via
a medical statistician within the Research
and Development department at Moorelds
Eye Hospital. The statistician was phoned
shortly before surgery after patients had
provided written informed consent and
been registered into the trial. Sequentially
numbered sealed opaque envelopes were
available as a backup facility.”
Blinding of participants and personnel
All outcomes
Low risk Quote: “The surgeons performing the
surgery and staff reviewing the patient at
4 months were not masked to the IOL in-
serted. However, patients were masked to
the lens group.”
Blinding of outcome assessors
All outcomes
High risk Judgement comment: the surgeons per-
forming the surgery and staff reviewing the
participant at 4 months were not masked
to the IOL inserted. However, participants
were masked to the lens group
Incomplete outcome data
All outcomes
Low risk Quote: “We planned to conduct the anal-
ysis according to the intent-to-treat princi-
pal. Primary outcome data were not avail-
able on 12% of patients. We compared
missing rates between treatment groups
and assessed whether missingness was asso-
ciated with any baseline covariate. We then
conducted an available case analysis.”
Selective outcome reporting High risk Judgement comment: some differences be-
tween outcomes on trial register and those
reported, e.g. reading speed
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Zhao 2010
Methods Study design: randomised controlled trial
Study grouping: parallel group
Surgery in 1 eye only
Multicentre: no
Participants Baseline characteristics
Multifocal: AcrySof ReSTOR SA60D3, Alcon Laboratories
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 72 (72)
• Mean age in years (range): 65 (34 to 80)
• % female: 49
• Ethnic group: NR
Monofocal: AcrySof SA60AT, Alcon Laboratories
• Number of people (eyes) randomised: NR
• Number of people (eyes) excluded after randomisation: NR
• Number of people (eyes) lost to follow-up: NR
• Number of people (eyes) analysed (at longest time point): 89 (72)
• Mean age in years (range): 67 (51 to 92)
• % female: 46
• Ethnic group: NR
Inclusion criteria: corrected distance VA and uncorrected distance VA < 10/25; nuclear
hardness from grade II to IV (Emery-Little classification); corneal astigmatism < 1.50
D; corneal endothelium cell count > 2000 cells/mm2; ability to understand and sign an
informed consent form
Exclusion criteria: aged < 21 years; myopia or hyperopia > 3.00D; history of amblyopia;
fundus abnormalities that could cause significant visual impairment; previous intraoc-
ular surgery; ocular comorbidity (e.g. previous trauma, glaucoma, diabetic retinopathy,
pseudoexfoliation syndrome, chronic uveitis, corneal opacity, senile miosis hyporeactive
pupil; alpha-antagonist (tamsulosin) treatment because of risk of floppy-iris syndrome;
intraoperative iris pupil trauma, vitreous loss and IOL implantation outside the capsular
bag
Pretreatment: no important differences between study groups
Interventions Intervention characteristics
Multifocal
• Name of lens: AcrySof ReSTOR SA60D3, Alcon Laboratories
• Type of lens: diffractive
• Target: NR
Monofocal
• Name of lens: AcrySof SA60AT, Alcon Laboratories
• Type of lens: NA
• Target: NR
1 eye operated
Outcomes Outcomes: distance and near VA, contrast sensitivity, defocus curves, aberrations, visual
function (VF-7), satisfaction, spectacle independence, adverse effects (including PCO,
glare, etc.)
Eyes: 1 eye per person
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Zhao 2010 (Continued)
Maximum follow-up: 6 months after surgery
Notes Sponsorship source: NR
Declaration of interest: “No author has a financial or proprietary interest in anymaterial
or method mentioned.”
Country: China
Setting:Department ofOphthalmology, AffiliatedHospital ofQingdaoUniversityMed-
ical College
Date study conducted: October 2005 and March 2007
Trial registration ID number: NR
Author’s name: Guiqui Zhao
Institution: Affiliated Hospital of Qingdao University Medical College
Email: zhaoguiqin-good@126.com
Address:Department of Ophthalmology, the Affiliated Hospital of Qingdao University
Medical College, Qingdao, 266003, China
Risk of bias
Bias Authors’ judgement Support for judgement
Sequence generation Low risk Quote: “Immediately preoperatively, the
patients were randomised with a coin toss
to receive an AcrySof SA60AT single-piece
monofocal IOL (monofocal group) or an
AcrySof ReSTORSA60D3multifocal IOL
(multifocal group) (both Alcon, Inc.).”
Allocation concealment Unclear risk Judgement comment: not described.
Blinding of participants and personnel
All outcomes
Unclear risk Judgement comment: participants and
medical staff collecting dataweremasked to
the IOL. However no description of mask-
ing of staff providing care
Blinding of outcome assessors
All outcomes
Low risk Judgement comment: the participants and
the medical staff who collected visual func-
tion and quality-of-life data were masked
to the type of IOL each participant received
Incomplete outcome data
All outcomes
Unclear risk Judgement comment: follow-up NR.
Selective outcome reporting Unclear risk Judgement comment: no access to study
protocol or trials registry entry
BCVA: best-corrected visual acuity; D: dioptre; IOL: intraocular lens; n: number of participants; NA: not applicable; NR: not reported;
PCO: posterior capsule opacification; SE: spherical equivalent; VA: visual acuity.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alio 2011a Participants not randomly allocated to intervention.
Alio 2011b Participants not randomly allocated to intervention.
Alio 2011c Participants not randomly allocated to intervention.
Alio 2015 Participants not randomly allocated to intervention.
Allen 2009 Participants not randomly allocated to intervention.
Cionni 2009 Participants not randomly allocated to intervention.
Hayashi 2009a Participants not randomly allocated to intervention.
Hayashi 2009b Participants not randomly allocated to intervention.
Hayashi 2009c Participants not randomly allocated to intervention.
Hayashi 2010 Participants not randomly allocated to intervention.
Hida 2009 Participants not randomly allocated to intervention.
Huang 2010 Chinese-speaking Cochrane author spoke to trialists and confirmed to us that participants were not ran-
domly allocated to the interventions
Ji 2011 Chinese-speaking Cochrane author spoke to trialists and confirmed to us that participants were not ran-
domly allocated to the interventions
Liang 2005 Chinese-speaking Cochrane author spoke to trialists and confirmed to us that participants were not ran-
domly allocated to the interventions
Maxwell 2008 Participants not randomly allocated to intervention.
NCT01088282 Trial was cancelled and never conducted. Personal communication with author
Ortiz 2008 Participants not randomly allocated to intervention.
Puell 2015 Participants not randomly allocated to intervention.
Richter-Mueksch 2002 Not randomised, case-control study.
Rocha 2005 Participants not randomly allocated to intervention.
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Shah 2010 Retrospective study.
Souza 2006 Participants not randomly allocated to intervention.
Walkow 1997 Randomised trial comparing diffractive with refractive design multifocal IOLs. Excluded because of the
lack of a monofocal control group
Xu 2007 Chinese-speaking Cochrane author spoke to trialists and confirmed to us that participants were not ran-
domly allocated to the interventions
Zhang 2011 Participants not randomly allocated to intervention.
IOL: intraocular lens.
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D A T A A N D A N A L Y S E S
Comparison 1. Multifocal versus monofocal intraocular lenses
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Unaided distance visual acuity
(VA) worse than 6/6
8 682 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.89, 1.03]
2 Mean unaided distance VA 6 Mean Difference (IV, Random, 95% CI) Totals not selected
3 Corrected distance VA worse
than 6/6
8 Risk Ratio (M-H, Random, 95% CI) Totals not selected
4 Mean corrected distance VA 6 Mean Difference (IV, Random, 95% CI) Totals not selected
5 Mean intermediate VA 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 Unaided 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 Corrected 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Unaided near VA worse than J3/
J4 or equivalent
8 782 Risk Ratio (M-H, Random, 95% CI) 0.20 [0.07, 0.58]
7 Mean unaided near VA 5 Mean Difference (IV, Random, 95% CI) Totals not selected
8 Corrected near VA worse than
J3/J4 or equivalent
4 344 Risk Ratio (M-H, Random, 95% CI) 0.32 [0.08, 1.27]
9 Mean corrected near VA 6 Mean Difference (IV, Random, 95% CI) Totals not selected
10 Spectacle dependence (any) 10 1000 Risk Ratio (M-H, Random, 95% CI) 0.63 [0.55, 0.73]
11 Spectacle dependence (distance
or near)
6 Risk Ratio (M-H, Random, 95% CI) Subtotals only
11.1 Distance 4 618 Risk Ratio (M-H, Random, 95% CI) 0.71 [0.46, 1.09]
11.2 Near 6 772 Risk Ratio (M-H, Random, 95% CI) 0.53 [0.40, 0.71]
12 Contrast sensitivity 4 288 Mean Difference (IV, Random, 95% CI) -0.09 [-0.26, 0.08]
13 Participant-reported outcomes:
visual function questionnaires
4 Mean Difference (IV, Random, 95% CI) Totals not selected
14 Participant-reported outcomes:
vision-related quality-of-life
questionnaires
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
15 Participant-reported outcomes:
satisfaction scores
6 Std. Mean Difference (IV, Random, 95% CI) Totals not selected
16 Participant-reported outcomes:
“good” or “satisfied” with
vision
4 Risk Ratio (M-H, Random, 95% CI) Subtotals only
16.1 Overall 4 344 Risk Ratio (M-H, Random, 95% CI) 0.97 [0.86, 1.08]
16.2 Near vision 1 80 Risk Ratio (M-H, Random, 95% CI) 1.42 [1.13, 1.78]
16.3 Distance vision 1 80 Risk Ratio (M-H, Random, 95% CI) 0.89 [0.72, 1.10]
17 Participant-reported outcomes:
other data on satisfaction
Other data No numeric data
18 Participant-reported outcomes:
cataract symptom scores
2 257 Mean Difference (IV, Fixed, 95% CI) 1.01 [0.39, 1.64]
19 Participant-reported outcomes:
glare
7 544 Risk Ratio (M-H, Random, 95% CI) 1.41 [1.03, 1.93]
20 Participant-reported outcomes:
haloes
7 662 Risk Ratio (M-H, Random, 95% CI) 3.58 [1.99, 6.46]
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21 Participant-reported outcomes:
dysphotopsia
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 2. Multifocal versus monovision
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Visual acuity (VA) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Mean unaided distance
VA
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Mean unaided
intermediate VA
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Mean unaided near VA 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Spectacle dependence 2 Risk Ratio (IV, Fixed, 95% CI) Subtotals only
2.1 Overall 2 262 Risk Ratio (IV, Fixed, 95% CI) 0.40 [0.30, 0.53]
2.2 Near vision 1 75 Risk Ratio (IV, Fixed, 95% CI) 0.40 [0.22, 0.70]
2.3 Distance vision 1 75 Risk Ratio (IV, Fixed, 95% CI) 1.54 [0.27, 8.70]
3 Contrast sensitivity 2 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4 Participant-reported outcomes:
visual function
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 Overall VF-14 score 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 Near vision VF-14 score 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 Distance vision VF-14
score
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Participant-reported outcomes:
glare
1 Risk Ratio (IV, Fixed, 95% CI) Totals not selected
6 Participant-reported outcomes:
glare mean score
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7 Participant-reported outcomes:
shadows mean score
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
A D D I T I O N A L T A B L E S
Table 1. Risk of bias assessment
Domain Low risk of bias Unclear risk of bias High risk of bias
Sequence generation Computer-generated list, ran-
dom table, other method of
generating random list
Not reported how list was gen-
erated.Trialmay be described as
“randomised” but with no fur-
ther details
Alternate allocation, date of
birth, records (these RCTs were
excluded)
Allocation concealment Central centre (web/telephone
access), sealed opaque
envelopes
Not reported how allocation
administered. Trial may be de-
scribed as “randomised” but
with no further details
Investigator involved in treat-
ment allocation or treatment al-
location clearly not masked
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Table 1. Risk of bias assessment (Continued)
Masking of participants and
personnel
Clearly stated that participants
and personnel (apart from sur-
geon) not aware of which lens
received
Described as “double blind”
with no information on who
was masked
No information on masking.
As lenses were different, we as-
sumed that in the absence of re-
porting on this participants and
personnel were not masked
Masking of outcome assessors Clearly stated that outcome as-
sessors were masked.
Described as “double blind”
with no information on who
was masked
No information on masking.
As lenses were different, we as-
sumed that in absence of report-
ing on this outcome assessors
were not masked
Incomplete outcome data Missing data < 20% (i.e. > 80%
follow-up) and equal follow-up
in both groups and no obvi-
ous reason why loss to follow-
up should be related to outcome
Follow-up not reported ormiss-
ing data > 20% (i.e. follow-up
< 80%) but follow-up equal in
both groups
Follow-up different in each
group or related to outcome (or
both)
Selective outcome reporting All outcomes in protocol or tri-
als registry entry (or both) are
reported
No access to protocol or trials
registry entry.
Outcomes in protocol or trials
registry entry (or both) selec-
tively reported
Other sources of bias No other source of bias. Trial stopped early due to poor
recruitment.
Baseline imbalance but not
clear that it is important.
Trial stopped early because of
outcome.
Important baseline imbalance
that might have an effect on the
results
RCT: randomised controlled trial.
Table 2. Included studies
Study Country Multicen-
tre?
Eyes oper-
ated
Number of
people ran-
domised
Number of
people ran-
domised
(assum-
ing same as
number
analysed
when not
reported)
Number of
people
included in
the analysis
Num-
ber of eyes
included in
the analysis
For eye out-
comes, re-
porting by
eye or per-
son?
Cillino
2008
Italy No Both NR 62 62 124 Eye (no ad-
justment for
within-per-
son correla-
tion)
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Table 2. Included studies (Continued)
el Maghraby
1992
Saudi Arabia No 1 77 77 61 61 Eye (unilat-
eral surgery)
Haaskjold
1998a
Europe Yes 1 NR 221 221 221 Eye (unilat-
eral surgery)
Harman
2008
England No Both 60 60 43 86 Person
Javitt 2000 USA, Ger-
many, Aus-
tria
Yes Both 261 261 235 470 Person
Ji 2013 China No 1 or both NR 51 51 64 Eye (no ad-
justment for
within-per-
son correla-
tion)
Jusufovic
2011
Bosnia and
Herzegovina
No 1 NR 100 100 100 Eye (unilat-
eral surgery)
Kamlesh
2001
India No 1 NR 40 40 40 Eye (unilat-
eral surgery)
Labiris 2015 Greece No Both 75 75 75 150 -
Leyland
2002
England No Both 69 69 60 120 Person
Nijkamp
2004
Netherlands No Both 190 190 137 274 Unclear
Palmer 2008 Spain No Both NR 114 114 228 Eye (no ad-
justment for
within-per-
son correla-
tion)
Peng 2012 China No Both 102 102 101 202 Eye (no ad-
justment for
within-per-
son correla-
tion)
Percival
1993
England No 1 NR 50 50 50 Eye (unilat-
eral surgery)
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Table 2. Included studies (Continued)
Rasp 2012 Austria No Both NR 146 146 292 Eye (no ad-
justment for
within-per-
son correla-
tion)
Rossetti
1994
Italy No 1 NR 80 80 80 Eye (unilat-
eral surgery)
Sen 2004 Finland No 1 or both 80 80 75 110 Eye (no ad-
justment for
within-per-
son correla-
tion)
Steinert
1992
USA Yes 1 80 80 62 62 Eye (unilat-
eral surgery)
Wilkins
2013
England Yes Both 211 211 187 374 Person
Zhao 2010 China No 1 NR 161 161 161 Eye (unilat-
eral surgery)
Total 2230 2061 3194
NR: not reported.
Table 3. Age and sex of participants in included studies
Study Mean age in years (range) % female
Multifo-
cal 1
Multifo-
cal 2
Multifo-
cal 3
Multifo-
cal 4
Monofo-
cal
Multifo-
cal 1
Multifo-
cal 2
Multifo-
cal 3
Multifo-
cal 4
Monofo-
cal
Cillino
2008
57 65 60 - 68 56 47 63 - 47
el
Maghraby
1992
57 (45 to
90)
- - - 56 (45 to
70)
59 - - -
Haaskjold
1998a
67 (max
88)
- - - 67 (max
90)
- - - - -
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Table 3. Age and sex of participants in included studies (Continued)
Harman
2008
73 - - - 71 50 - - - 60
Javitt
2000
74 - - - 75 51 - - - 61
Ji 2013 63 (52 to
71)
- - - 63 (55 to
75)
58 - - - 56
Jusufovic
2011
43 (20 to
57)
- - - 50 (26 to
64)
46 - - - 42
Kamlesh
2001
56 - - - 54 - - - - -
Labiris
2015
61 - - - 60 - - - - -
Leyland
2002
75 74 NA - 76 53 60 - - 44
Nijkamp
2004
72 - - - 72 67 - - - 64
Palmer
2008
73 72 74 - 75 61 69 67 - 53
Peng
2012
66 NA NA - 67 58 - - - 47
Percival
1993
77 (59 to
89)
- - - 78 (60 to
92)
58 - - - 58
Rasp
2012
76 (62 to
91)
74 (63 to
89)
79 (66 to
89)
75 (62 to
87)
76 (63 to
80)
- - - - -
Rossetti
1994
72 (55 to
84)
- - - 70 (50 to
90)
61 - - - 57
Sen 2004 69 (48 to
84)
- - - 72 (41 to
88)
74 - - - 63
Steinert
1992
72 - - - 71 55 - - - 78
Wilkins
2013
67 - - - 69 56 - - - 58
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Table 3. Age and sex of participants in included studies (Continued)
Zhao
2010
65 (34 to
80)
- - - 67 (51 to
92)
49 - - - 46
max: maximum; NA: not applicable.
Table 4. Lenses used in included studies
Study Multifocal lens model (manufacturer) type Monofocal lens name (manufacturer)
Cillino 2008 Array SA40N
(AMO)
refractive
AR40
(AMO)
ReZoom
(AMO)
refractive
Tecnis ZM900
(AMO)
diffractive
el Maghraby 1992 815LE
(3M Vision Care)
diffractive
15LE
(3M Vision Care)
Haaskjold 1998a 808X
(Pharmacia Ophthalmics)
diffractive bifocal
808D
(Pharmacia Ophthalmics)
Harman 2008 Array SA40N
(AMO)
refractive
Clariflex
(AMO)
Javitt 2000 Array SA40N
(AMO)
refractive
PhacoFlex II SI40NB
(AMO)
Ji 2013 AcrySof ReSTOR
(Alcon Laboratories)
diffractive
AcrySof Natural
(Alcon Laboratories)
Jusufovic 2011 ReZoom NXG1
(AMO)
refractive
AcrySof MA60BM
(Alcon Laboratories)
Kamlesh 2001 Progress 3
(Laboratoires Domilens)
refractive
Flex 65
(Laboratoires Domilens)
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Table 4. Lenses used in included studies (Continued)
Labiris 2015 Isert PY60MV (Hoya Surgical Optics) SN60WF (Alcon Laboratories)
Leyland 2002 Array SA40NB
(Allergan)
refractive
PhacoFlex I SI40N
(Allergan)
TrueVista 68STUV
(Storz)
refractive
Nijkamp 2004 Array SA40N
(AMO)
refractive
PhacoFlex II SI40NB
(AMO)
Palmer 2008 Tecnis ZM900
(AMO)
diffractive
Tecnis Z9000
(AMO)
ReZoom
(AMO)
refractive
TwinSet
(Acri.Tec, GmbH)
diffractive
Peng 2012 AcrySof ReSTOR SN6AD1
(Alcon Laboratories)
diffractive
AcrySof IQ SN60WF
(Alcon Laboratories)
Percival 1993 MPC25
(AMO)
refractive
PC25
(AMO)
Rasp 2012 AcrySof ReSTOR SN6AD3
(Alcon Laboratories)
diffractive
Acri.Smart 48S (also known as CT Spheris 209M)
(Carl Zeiss)
AT LISA 366D
(Carl Zeiss)
diffractive
ReZoom (AMO)
refractive
Tecnis ZMA00
(AMO)
diffractive
Rossetti 1994 3M lens “with both refractive and diffractive optics” Model not reported
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Table 4. Lenses used in included studies (Continued)
Sen 2004 Array SA40N
(AMO)
refractive
PhacoFlex II SI40NB
(AMO)
Steinert 1992 Array MPC-25NB
(AMO)
refractive
PC-25NB
(AMO)
Wilkins 2013 Tecnis ZM900
(AMO)
diffractive
Akreos AO
(Bausch & Lomb)
Zhao 2010 AcrySof ReSTOR SA60D3
(Alcon Laboratories)
diffractive
AcrySof SA60AT
(Alcon Laboratories)
AMO: Advanced Medical Optics.
Table 5. Refractive aims in included studies
Study ID Refractive aim
Cillino 2008 Emmetropia
el Maghraby 1992 Emmetropia
Haaskjold 1998a Not stated
Harman 2008 Emmetropia
Javitt 2000 Not stated
Ji 2013 Not stated
Jusufovic 2011 Not stated
Kamlesh 2001 Not stated
Labiris 2015 Multifocal: +3.00 D of near addition; monofocal (monovision): targeting -0.50 D in the dominant eye and -1.
25 D in the non-dominant eye
Leyland 2002 Emmetropia
Nijkamp 2004 Within 1 D of emmetropia
Palmer 2008 Between emmetropia and -0.5 D for monofocal emmetropia for multifocal
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Table 5. Refractive aims in included studies (Continued)
Peng 2012 Emmetropia
Percival 1993 Emmetropia (treatment)/myopic astigmatism (control)
Rasp 2012 Not stated
Rossetti 1994 < 2 D astigmatism
Sen 2004 Not stated
Steinert 1992 Not stated
Wilkins 2013 Multifocal: emmetropia Monofocal (monovision): Emmetropia in distance eye; myopia -1.0 D to -1.5 D in the
near eye
Zhao 2010 Not stated
D: dioptre.
Table 6. Subgroup analyses: refractive versus diffractive lenses
Outcome Effect
measure
Analysis
model
Studies Number of eyes Effect estimate
(95% CI)
I2 Test for interaction (P
value)
Unaided dis-
tance VA
worse than 6/
6
RR Random 8 682 0.96
(0.89,1.03)
13.62 0.22
Both
refractive and
diffractive op-
tics
RR Random 1 80 1.02
(0.89,1.17)
0.00 -
Refractive RR Random 5 392 0.91
(0.83,0.99)
0.00 -
Diffractive RR Random 2 210 1.06
(0.87,1.30)
26.32 -
Mean
unaided dis-
tance VA
(logMAR)
MD Random 8 924 0.01
(-0.02,0.05)
69.87 0.91
Refractive MD Random 5 414 0.01
(-0.01,0.04)
0.00 -
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Table 6. Subgroup analyses: refractive versus diffractive lenses (Continued)
Diffractive MD Random 3 510 0.02
(-0.05,0.09)
89.72 -
Corrected
distance VA
worse than 6/
6
RR Random 8 692 1.02
(0.71,1.45)
53.97 0.24
Both
refractive and
diffractive op-
tics
RR Random 1 80 1.05
(0.65,1.68)
0.00 -
Refractive RR Random 5 332 0.84
(0.50,1.41)
46.89 -
Diffractive RR Random 2 280 1.44
(0.97,2.13)
0.00 -
Mean
corrected dis-
tance VA
(logMAR)
MD Random 8 924 0.03
(0.02,0.05)
55.65 0.92
Refractive MD Random 5 414 0.04
(0.00,0.07)
68.47 -
Diffractive MD Random 3 510 0.03
(0.02,0.05)
31.97 -
Mean
unaided
intermediate
VA (logMAR)
No subgroup analysis because only 1 subgroup - diffractive (1 trial)
Mean
corrected in-
termediate
VA (logMAR)
No subgroup analysis because only 1 subgroup - diffractive (1 trial)
Unaided near
VA worse
than J3/J4 or
equivalent
RR Random 8 782 0.20
(0.07,0.63)
93.38 0.88
Both
refractive and
diffractive op-
tics
RR Random 1 80 0.22
(0.09,0.52)
0.00 -
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Table 6. Subgroup analyses: refractive versus diffractive lenses (Continued)
Refractive RR Random 4 442 0.21
(0.03,1.63)
95.35 -
Diffractive RR Random 3 260 0.16
(0.07,0.40)
62.77 -
Mean un-
aided near VA
(logMAR)
MD Random 6 881 -0.20
(-0.37,-0.03)
98.28 0.13
Refractive MD Random 4 453 -0.11
(-0.19,-0.03)
81.28 -
Diffractive MD Random 2 428 -0.39
(-0.74,-0.03)
99.26 -
Corrected
near VA
worse
than J3/J4 or
equivalent
RR Random 4 344 0.32
(0.08,1.27)
17.58 0.18
Both
refractive and
diffractive op-
tics
RR Random 1 80 0.55
(0.05,5.85)
0.00 -
Refractive RR Random 1 59 2.90
(0.12,68.50)
0.00 -
Diffractive RR Random 2 205 0.12
(0.02,0.61)
0.00 -
Mean cor-
rected near
VA (logMAR)
MD Random 8 1079 -0.05
(-0.15,0.05)
98.11 0.29
Refractive MD Random 5 569 0.02
(-0.02,0.06)
83.89 -
Diffractive MD Random 3 510 -0.17
(-0.52,0.18)
99.40 -
Contrast sen-
sitivity
MD Random 4 288 -0.07
(-0.15,0.00)
0.00 0.60
Both
refractive and
MD Random 1 80 -0.03
(-0.23,0.17)
0.00 -
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Table 6. Subgroup analyses: refractive versus diffractive lenses (Continued)
diffractive op-
tics
Refractive MD Random 3 208 -0.09
(-0.20,0.02)
2.89 -
Diffractive MD Random 1 0 -
Participant-
reported out-
comes: visual
function
question-
naires
MD Random 5 495 4.43
(-0.79,9.66)
90.66 0.02
Refractive MD Random 3 303 0.65
(-4.60,5.89)
69.05 -
Diffractive MD Random 2 192 8.88
(4.81,12.95)
55.23 -
Participant-
reported
outcomes: vi-
sion-re-
lated quality-
of-life ques-
tionnaires
No subgroup analysis because only 1 subgroup - diffractive (1 trial)
Participant-
reported out-
comes: satis-
faction scores
SMD Random 7 658 0.24
(-0.20,0.68)
86.02 0.00
Refractive SMD Random 4 365 -0.10
(-0.32,0.11)
5.78 -
Diffractive SMD Random 3 293 0.83
(0.42,1.23)
57.33 -
Participant-
reported out-
comes:
“good”
or “satisfied”
with vision
RR Random 4 388 0.99
(0.92,1.06)
0.00 0.64
Both
refractive and
diffractive op-
RR Random 1 80 0.87
(0.67,1.14)
0.00 -
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Table 6. Subgroup analyses: refractive versus diffractive lenses (Continued)
tics
Refractive RR Random 2 159 1.00
(0.91,1.09)
0.00 -
Diffractive RR Random 1 149 0.99
(0.87,1.13)
0.00 -
Participant-
reported out-
comes:
cataract
symptom
scores
No subgroup analysis because only 1 subgroup - refractive (2 trials)
Participant-
reported out-
comes: glare
RR Random 8 559 1.41
(1.03,1.93)
0.00 0.68
Both
refractive and
diffractive op-
tics
RR Random 1 80 0.97
(0.39,2.41)
0.00 -
Refractive RR Random 5 299 1.50
(1.05,2.14)
0.00 -
Diffractive RR Random 2 180 1.34
(0.50,3.62)
0.00 -
Participant-
reported out-
comes: halos
RR Random 8 677 3.58
(2.06,6.25)
19.65 1.00
Both
refractive and
diffractive op-
tics
RR Random 1 80 4.86
(2.05,11.56)
0.00 -
Refractive RR Random 4 256 4.65
(1.59,13.60)
0.00 -
Diffractive RR Random 3 341 4.53
(0.81,25.30)
54.02 -
Participant-
reported out-
comes:
dysphotopsia
RR Random 2 138 1.13
(0.81,1.60)
0.00 0.54
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Table 6. Subgroup analyses: refractive versus diffractive lenses (Continued)
Refractive RR Random 1 56 1.00
(0.59,1.70)
0.00 -
Diffractive RR Random 1 82 1.24
(0.79,1.94)
0.00 -
Spectacle de-
pendence
RR Random 11 1015 0.63
(0.54,0.73)
68.19 0.04
Both
refractive and
diffractive op-
tics
RR Random 1 80 0.57
(0.41,0.78)
0.00 -
Refractive RR Random 6 493 0.74
(0.67,0.80)
0.00 -
Diffractive RR Random 4 442 0.43
(0.26,0.71)
82.56 -
CI: confidence interval; MD: mean difference; RR: risk ratio; SMD: standardised mean difference; VA: visual acuity.
Table 7. Subgroup analyses: unilateral versus bilateral surgery
Outcome Effect
measure
Analysis
model
Studies Number of eyes Effect estimate
(95% CI)
I2 Test for interaction (P
value)
Unaided dis-
tance VA
worse than 6/
6
RR Random 8 682 0.96
(0.89,1.03)
13.62 0.75
Unilateral RR Random 6 502 0.98
(0.88,1.08)
33.14 -
Bilateral RR Random 1 60 0.85
(0.25,2.89)
0.00 -
Mixed unilat-
eral/bilateral
RR Random 1 120 0.92
(0.80,1.05)
100.00 -
Mean
unaided dis-
tance VA
(logMAR)
No subgroup analysis because only 1 subgroup - bilateral (6 trials)
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Table 7. Subgroup analyses: unilateral versus bilateral surgery (Continued)
Corrected
distance VA
worse than 6/
6
RR Random 8 692 1.02
(0.71,1.45)
53.97 0.00
Unilateral RR Random 6 512 1.24
(0.96,1.62)
0.00 -
Bilateral RR Random 1 60 0.73
(0.15,3.60)
0.00 -
Mixed unilat-
eral/bilateral
RR Random 1 120 0.61
(0.43,0.85)
0.00 -
Mean
corrected dis-
tance VA
(logMAR)
No subgroup analysis because only 1 subgroup - bilateral (6 trials)
Mean
unaided
intermediate
VA (logMAR)
MD Fixed 1 0 - - -
Mean
corrected in-
termediate
VA (logMAR)
MD Fixed 1 0 - - -
Unaided near
VA worse
than J3/J4 or
equivalent
RR Random 8 782 0.20
(0.07,0.58)
92.77 0.89
Unilateral RR Random 5 426 0.20
(0.08,0.51)
73.56 -
Bilateral RR Random 2 292 0.27
(0.01,6.63)
97.36 -
Mixed unilat-
eral/bilateral
RR Random 1 64 0.15
(0.06,0.38)
0.00 -
Mean un-
aided near VA
(logMAR)
No subgroup analysis because only 1 subgroup - bilateral (5 trials)
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Table 7. Subgroup analyses: unilateral versus bilateral surgery (Continued)
Corrected
near VA
worse
than J3/J4 or
equivalent
No subgroup analysis because only 1 subgroup - unilateral (4 trials)
Mean cor-
rected near
VA (logMAR)
No subgroup analysis because only 1 subgroup - bilateral (6 trials)
Contrast sen-
sitivity
MD Random 4 288 -0.09
(-0.26,0.08)
0.00 0.37
Unilateral MD Random 1 80 -0.03
(-0.23,0.17)
0.00 -
Bilateral MD Random 2 88 -0.10
(-0.47,0.27)
0.00 -
Mixed unilat-
eral/bilateral
MD Random 1 120 -0.40
(-0.87,0.07)
0.00 -
Participant-
reported out-
comes: visual
function
question-
naires
MD Random 4 480 3.09
(-2.77,8.96)
92.18 0.00
Unilateral MD Random 1 161 7.50
(5.95,9.05)
0.00 -
Bilateral MD Random 2 199 3.54
(-5.90,12.97)
88.24 -
Mixed unilat-
eral/bilateral
MD Random 1 120 -3.60
(-10.19,2.99)
0.00 -
Participant-
reported
outcomes: vi-
sion-re-
lated quality-
of-life ques-
tionnaires
MD Fixed 1 0
Participant-
reported out-
comes: satis-
SMD Random 6 643 0.26
(-0.21,0.73)
87.75 0.91
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Table 7. Subgroup analyses: unilateral versus bilateral surgery (Continued)
faction scores
Unilateral SMD Random 2 223 0.24
(-0.92,1.40)
93.35 -
Bilateral SMD Random 3 300 0.31
(-0.55,1.18)
91.45 -
Mixed unilat-
eral/bilateral
SMD Random 1 120 0.12
(-0.24,0.48)
0.00 -
Participant-
reported out-
comes:
“good”
or “satisfied”
with vision
RR Random 1 0
Unilateral RR Random 3 269 0.96
(0.85,1.07)
0.00 -
Mixed unilat-
eral/bilateral
RR Random 1 119 1.00
(0.92,1.10)
0.00 -
Participant-
reported out-
comes:
cataract
symptom
scores
MD Fixed 2 257 1.01
(0.39,1.64)
0.00 0.57
Bilateral MD Fixed 1 137 0.90
(0.16,1.64)
0.00 -
Mixed unilat-
eral/bilateral
MD Fixed 1 120 1.30
(0.12,2.48)
0.00 -
Participant-
reported out-
comes: glare
RR Random 7 544 1.41
(1.03,1.93)
0.00 0.33
Unilateral RR Random 4 319 1.31
(0.77,2.21)
0.00 -
Bilateral RR Random 2 105 2.05
(1.12,3.75)
0.00 -
Mixed unilat-
eral/bilateral
RR Random 1 120 1.14
(0.67,1.92)
0.00 -
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Table 7. Subgroup analyses: unilateral versus bilateral surgery (Continued)
Participant-
reported out-
comes: halos
RR Random 7 662 3.58
(1.99,6.46)
24.75 0.69
Unilateral RR Random 5 480 3.50
(1.70,7.19)
36.86 -
Bilateral RR Random 1 62 12.33 (0.79,
193.20)
0.00 -
Mixed unilat-
eral/bilateral
RR Random 1 120 3.79
(0.80,18.03)
0.00 -
Participant-
reported out-
comes:
dysphotopsia
RR Random 1 114 1.18
(0.76,1.82)
0.00 1.00
Spectacle de-
pendence
RR Random 10 1000 0.63
(0.55,0.73)
66.86 0.81
Unilateral RR Random 5 499 0.62
(0.51,0.75)
58.74 -
Bilateral RR Random 5 501 0.64
(0.51,0.80)
73.16 -
CI: confidence interval; RR: risk ratio; VA: visual acuity.
Table 8. Sensitivity analysis: excluding studies at high risk of bias
Outcome Effect
measure
All trials Excluding studies at high risk of bias in ≥ 1 domain
Number
of studies
Number
of eyes
Effect esti-
mate
(95% CI)
I2 Number of
studies
Number of
eyes
Effect esti-
mate (95%
CI)
I2
Un-
aided dis-
tance VA
worse than
6/6
RR 8 682 0.96
(0.89,1.
03)
13.62 1 60 0.85
(0.25,2.89)
0.00
Mean un-
aided dis-
tance VA
(logMAR)
MD 6 848 0.01
(-0.03,0.
05)
74.32 2 262 -0.01
(-0.10,0.08)
81.23
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Table 8. Sensitivity analysis: excluding studies at high risk of bias (Continued)
Cor-
rected dis-
tance VA
worse than
6/6
RR 8 692 1.02
(0.71,1.
45)
53.97 1 60 0.73
(0.15,3.60)
0.00
Mean cor-
rected dis-
tance VA
(logMAR)
MD 6 848 0.03
(0.01,0.
06)
63.79 2 262 0.02
(0.00,0.04)
0.00
Mean un-
aided
intermedi-
ate VA
(logMAR)
Only 1 study reported this outcome
Mean cor-
rected in-
termediate
VA
(logMAR)
Only 1 study reported this outcome
Un-
aided near
VA worse
than J3/J4
or equiva-
lent
RR 8 782 0.20
(0.07,0.
58)
92.77 2 292 0.29
(0.01,8.39)
97.57
Mean un-
aided near
VA
(logMAR)
MD 5 829 -0.22
(-0.42,-0.
03)
98.41 3 494 -0.26
(-0.58,0.06)
98.94
Cor-
rected near
VA worse
than J3/J4
or equiva-
lent
All trials were high risk of bias in ≥ 1 domain
Mean cor-
rected near
VA
(logMAR)
MD 6 1003 -0.07
(-0.20,0.
06)
98.59 3 554 -0.16
(-0.50,0.18)
99.38
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Table 8. Sensitivity analysis: excluding studies at high risk of bias (Continued)
Contrast
sensitivity
MD 4 288 -0.09
(-0.26,0.
08)
0.00 1 45 -0.07
(-0.16,0.02)
0.00
Partici-
pant-
reported
out-
comes: vi-
sual func-
tion ques-
tionnaires
MD 4 480 3.09
(-2.77,8.
96)
92.18 2 223 7.58
(6.08,9.08)
0.00
Partici-
pant-
reported
outcomes:
vision-re-
lated qual-
ity-of-life
question-
naires
Only 1 study reported this outcome
Partici-
pant-
reported
outcomes:
satisfac-
tion scores
SMD 6 643 0.26
(-0.21,0.
73)
87.75 3 324 0.64
(0.00,1.28)
84.77
Partici-
pant-
reported
outcomes:
“good” or
“satisfied”
with vision
All trials were high risk of bias in ≥ 1 domain
Partici-
pant-
reported
outcomes:
cataract
symptom
scores
All trials were high risk of bias in ≥ 1 domain
Partici-
pant-
reported
RR 7 544 1.41
(1.03,1.
93)
0.00 1 62 2.23
(0.30,16.
72)
0.00
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Table 8. Sensitivity analysis: excluding studies at high risk of bias (Continued)
outcomes:
glare
Partici-
pant-
reported
outcomes:
halos
RR 7 662 3.58
(1.99,6.
46)
24.75 2 223 3.27
(0.64,16.
67)
45.56
Partici-
pant-
reported
outcomes:
dyspho-
topsia
Only 1 study reported this outcome
Specta-
cle depen-
dence
(any)
RR 10 1000 0.63
(0.55,0.
73)
66.86 5 619 0.55
(0.41,0.75)
83.77
CI: confidence interval; MD: mean difference; RR: risk ratio; SMD: standardised mean difference; VA: visual acuity.
F E E D B A C K
Savage, November 2004
Summary
The conclusions of the review abstract suggest that multifocals [intraocular lenses (IOL)] improved quality of near vision over the
monofocal IOL, however in several studies noted (ie: Javitt & Steinert) the refractive error targeted with monofocal IOLs is not
mentioned. It is thus assumed that emmetropia was the goal, rather than monovision. A better question is how do patients with
monovision IOL implants function compared to those with the Array [multifocal IOL] ? In my experience, patients prefer monovision!
There is no glare or halo, and the quality of vision is sufficient for most to function unaided, including night driving.
Reply
Thank you for your comments.
The studies in this meta-analysis recruited patients into RCTs [randomised controlled trials] comparing a multifocal lens with a
monofocal lens. None of the RCTs used monovision as either a control group or intervention group. Whilst this would be an interesting
study (glare and haloes may be less in the monofocal monovision group, possibly at the expense of troublesome anisometropia), this
scenario is not answered by this analysis.
Contributors
Edward Pringle, review co-author
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WH A T ’ S N E W
Last assessed as up-to-date: 13 June 2016.
Date Event Description
26 October 2016 New search has been performed Issue 12, 2016: Electronic searches were updated and 5
new trials were included (Ji 2013; Labiris 2015; Peng
2012; Rasp 2012;Wilkins 2013) and one previously in-
cluded study was excluded (Alio 2011c). The review has
been updated using current Cochrane methods and an
additional comparison, monovision, has been included
26 October 2016 New citation required but conclusions have not
changed
Issue 12, 2016: Three new authors have joined the au-
thor team: Samantha de Silva, Varo Kirthi and Mo-
hammed Ziaei
H I S T O R Y
Protocol first published: Issue 3, 2000
Review first published: Issue 3, 2001
Date Event Description
8 June 2012 New citation required but conclusions have not changed Three new authors, Daniel Calladine, Jennifer Evans and
Sweata Shah, worked on the 2012 update
8 June 2012 New search has been performed Updated searches yielded six new trials (Alio 2011;Cillino
2008; Harman 2008; Jusufovic 2011; Palmer 2008; Zhao
2010) for inclusion in the review
19 June 2008 Amended Converted to new review format.
9 July 2006 New citation required and conclusions have changed Substantive amendment.
C O N T R I B U T I O N S O F A U T H O R S
For the first edition of the review, ML decided the review scope, carried out some electronic database searches, performed additional
handsearches, assessed the results of searches, assessed suitability of studies, extracted data, wrote the text and updated the review.
In the 2016 edition of the review, SdeS, JE, VK and MZ screened studies, extracted data and assessed risk of bias. SdeS and JE updated
the text. VK and MZ should be considered as joint 3rd authors.
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D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• National Institute for Health Research (NIHR), UK.
• Richard Wormald, Co-ordinating Editor for the Cochrane Eyes and Vision (CEV) acknowledges financial support for his CEV
research sessions from the Department of Health through the award made by the NIHR to Moorfields Eye Hospital NHS
Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology.
• The NIHR also funds the CEV Editorial Base which includes part of Jennifer Evans’s salary.
• The Cochrane Incentive Scheme provided funding for Jennifer Evans to assist with updating this review in 2012.
The views expressed in this publication are those of the authors and not necessarily those of the NIHR, National Health Service or
the Department of Health.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The original protocol for this review was published in 2000. Since that time there have been substantive changes in recommended
Cochrane Review methodology.We have added in specific information on the following methodological issues: unit of analysis, missing
data and subgroup analysis.
For the update in 2016, we have collaborated with the National Institute of Care and Health Excellence (NICE) in the UK. NICE are
preparing guidelines for cataract management and we agreed to work with them to ensure that the information in this review provided
data relevant to the guideline. This mainly affected the comparisons and outcomes.
Types of interventions
We included an additional comparison: multifocal versus monovision. Monovision is a strategy designed to enable people to achieve
good distance and near vision by adjusting the powers of the lenses such that one eye is used for distance vision and one for near vision.
Outcomes
We have added in intermediate visual acuity as an outcome.
For the 2016 update, we dropped depth of focus because the data on this were sparse and difficult to interpret because of considerable
variability in measurement and reporting.
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Risk of bias
We used Cochrane’s tool for assessing the risk of bias (replacing the Jadad scale). In the 2012 update of this review, we assessed selective
outcome reporting bias by completing an outcome reporting matrix using the ORBIT classification (Kirkham 2010). In the 2016
update, we did not continue with this assessment but assessed selective outcome reporting as part of the risk of bias tool only.
Measures of treatment effect
For dichotomous outcomes, we changed the measure of effect from odds ratio to risk ratio, reflecting changing views as to the relative
suitability of the risk ratio/odds ratio as a measure of effect. Although the odds ratio has some statistical advantages, it is not as easily
interpreted as the risk ratio and may overestimate the effect of the intervention, particularly when the event occurs commonly within
the study population.
In the 2012 update of the review, we pooled visual acuity measured on different scales using the standardised mean difference. The
standardised mean difference is difficult to interpret, however, and there is accumulating evidence that different visual acuity charts
perform differently at different levels of visual acuity. For these reasons, we have changed our mind about the validity of doing this.
As more data were available measured on the logMAR scale we restricted our analyses to studies measuring and reporting visual acuity
data on the logMAR scale. We summarised these using the mean difference.
Subgroup analysis
We have added in an additional subgroup analysis comparing unilateral and bilateral surgery.
Sensitivity analysis
Following updated guidance from Cochrane (MECIR 2013), we have added in a sensitivity analysis excluding studies at high risk of
bias in one or more domains.
’Summary of findings’ table
We prepared a ’Summary of findings’ table, including assessing the quality of evidence using GRADE (GRADEpro 2014).
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Lenses, Intraocular [psychology]; Cataract Extraction [∗rehabilitation]; Contrast Sensitivity [physiology]; Patient Satisfaction; Pros-
thesis Design; Randomized Controlled Trials as Topic; Vision, Ocular [physiology]; Visual Acuity [∗physiology]
MeSH check words
Adult; Humans
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